Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1050.Time spend outdoors in summer,48916,0.0578298254507315,0.0423047142530983,-0.0250874144853412,0.140747065386804,0.171643193592751
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1060.Time spent outdoors in winter,45211,0.00302792795480706,0.0478269943023115,-0.0907129808777234,0.0967688367873375,0.949520246729525
PLA2G15,Phospholipase A2 group XV,Physical activities,X1070.Time spent watching television (TV),50491,0.27331291201283,0.0432977460400737,0.188449329774286,0.358176494251375,2.7915899097151e-10
PLA2G15,Phospholipase A2 group XV,Physical activities,X1080.Time spent using computer,45187,-0.15532499150402,0.0454529414009722,-0.244412756649925,-0.0662372263581142,0.000633738679964856
PLA2G15,Phospholipase A2 group XV,Physical activities,X1090.Time spent driving,42579,-0.211628870886377,0.0499031316425201,-0.309439008905716,-0.113818732867038,2.23835082001657e-05
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1160.Sleep duration,52031,-0.00448543570035819,0.0387583495822954,-0.0804518008816572,0.0714809294809408,0.907868764534823
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,34121,0.00794866161792004,0.00958148307257484,-0.0108310452043267,0.0267283684401667,0.406793528454362
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,34121,0.0113023242443515,0.00861855713721982,-0.00559004774459933,0.0281946962333024,0.189755819328735
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,34121,0.0133101547582741,0.0103268890248219,-0.00693054773037694,0.0335508572469251,0.197469497800314
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,34121,0.015730950529843,0.010581004007197,-0.00500781732426315,0.0364697183839492,0.137122376936491
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,34121,0.015369331478454,0.0106692753390368,-0.00554244818605814,0.0362811111429662,0.149752000340183
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,34121,0.00954484374702302,0.0206895162715969,-0.0310066081453068,0.0500962956393528,0.644567068930656
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,34121,0.0340768967284973,0.020419633601934,-0.00594558513129329,0.0740993785882878,0.0951834551656847
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,34121,0.0148094546249367,0.0156656792558454,-0.0158952767165203,0.0455141859663938,0.344506945520226
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,34121,0.0227162062268687,0.0112169204265,0.000731042190928663,0.0447013702628088,0.042877006844318
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,34121,0.0107073047200789,0.00775857016041583,-0.00449949279433615,0.0259141022344939,0.167599588076214
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#18.Location of pain during the past week_Upper back,34121,0.0219839861934959,0.0108182194211034,0.000780276128133202,0.0431876962588586,0.0421681697230263
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#19.Location of pain during the past week_Lower back,34121,0.00619600469319113,0.00660527280612342,-0.00675033000681077,0.019142339393193,0.348247705300326
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,34121,0.00622452063344869,0.00825862304800635,-0.00996238054064374,0.0224114218075411,0.451047993256274
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,34121,0.0172017482577056,0.0117894967903815,-0.00590566545144213,0.0403091619668532,0.144577225296614
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,34121,0.0198703429187892,0.0112628861056137,-0.00220491384821368,0.0419455996857921,0.0777245156600438
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,34121,0.0154184644860856,0.0158698080104607,-0.0156863592144173,0.0465232881865885,0.331293987480715
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,34121,-0.00127647298341407,0.0146996306063857,-0.03008774897193,0.0275348030051018,0.930802812334127
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#7.Location of pain during the past week_Left hip,34121,0.00472032963602781,0.00880606469169882,-0.0125395571597019,0.0219802164317575,0.591948987509672
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#8.Location of pain during the past week_Right hip,34121,0.015931062610772,0.0082241345412381,-0.000188241090054705,0.0320503663115986,0.0527608504979521
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,34121,0.0128504426261585,0.0109843989404172,-0.00867897929705916,0.0343798645493763,0.24207758649908
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120040.Fatigue severity over the past week,34127,0.242020099143869,0.0682760262032238,0.10819908778555,0.375841110502187,0.000394870681962721
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120041.Waking unrefreshed severity over the past week,34124,0.173130618361637,0.0678609273101284,0.0401232008337858,0.306138035889489,0.0107487946398566
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120042.Cognitive symptoms severity over the past week,34124,0.234896047518052,0.0734203901856888,0.0909920827541016,0.378800012282002,0.00138191948509822
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120098.Mobility problems today,34131,0.351355328890783,0.0807031793847475,0.193177097296678,0.509533560484888,1.35251475750818e-05
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120099.Self-care problems today,34131,0.280125044895386,0.125963002857294,0.0332375592950898,0.527012530495683,0.0261803456101517
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120100.Problems doing usual activities,34131,0.205270373195806,0.0760932911038472,0.0561275226322656,0.354413223759346,0.0069959302666681
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120101.Pain or discomfort today,34131,0.127871573491548,0.0688484399492979,-0.0070713688090758,0.262814515792172,0.063300155910861
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120102.Anxiety or depression today,34131,0.21585655403132,0.0801137146777564,0.058833673262918,0.372879434799723,0.00706420577550798
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120103.Scale to indicate how health is today,34093,-0.0117336068896361,0.00284739188854256,-0.0173144949911795,-0.0061527187880927,3.80674548611635e-05
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,34106,0.189585394240431,0.0818333618348725,0.0291920050440807,0.349978783436781,0.0205395469861982
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",34083,0.123241827793528,0.0826871399492791,-0.0388249665070593,0.285308622094115,0.136136230211905
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",34113,0.0613408974322976,0.0671056737777416,-0.070186223172076,0.192868018036671,0.360690243223021
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,34109,0.25938571167344,0.0692681706192333,0.123620097259743,0.395151326087137,0.000181688609978595
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,34116,0.210270610092067,0.0832145931151787,0.0471700075863165,0.373371212597817,0.0115249636774832
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120109.Feeling bad about self over the last two weeks,34086,0.0604742457093218,0.0860262760315361,-0.108137255312489,0.229085746731132,0.482088867515957
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120110.Trouble concentrating over the last two weeks,34112,0.142619308022688,0.0893598738887651,-0.0325260447992912,0.317764660844668,0.11051913950415
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,34104,0.20786923414741,0.130477441867083,-0.0478665519120724,0.463605020206892,0.111160847331953
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,34064,0.210179142981153,0.175658427102835,-0.134111374140403,0.554469660102709,0.231522502157946
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",31735,0.253244638896474,0.0886504384007513,0.079489779631001,0.426999498161946,0.00429329550309436
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1269.Exposure to tobacco smoke at home,49673,0.139327340622337,0.0932725789222677,-0.0434869140653081,0.322141595309981,0.135249487815597
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,47805,-0.0537165535598817,0.0609601700450691,-0.173198486848217,0.0657653797284538,0.378232392958799
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X1289.Cooked vegetable intake,51492,-0.194595540316262,0.0404678569440666,-0.273912539926633,-0.115278540705892,1.52773995596588e-06
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X1299.Salad  or  raw vegetable intake,50975,-0.283618737368314,0.0439511107750604,-0.369762914487433,-0.197474560249196,1.11511976811534e-10
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X1309.Fresh fruit intake,51525,-0.15995081364788,0.0420624263418422,-0.242393169277891,-0.0775084580178692,0.000143441298355874
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X1319.Dried fruit intake,49768,-0.219002477308402,0.0422638872970801,-0.301839696410679,-0.136165258206125,2.21454574210113e-07
PLA2G15,Phospholipase A2 group XV,Health and medical history,X134.Number of self-reported cancers,52317,0.192574783720246,0.0691775766427837,0.0569867335003898,0.328162833940102,0.00537665584369118
PLA2G15,Phospholipase A2 group XV,Health and medical history,X135.Number of self-reported non-cancer illnesses,52317,0.493646743813771,0.040831227108411,0.413617538681286,0.573675948946257,1.44892015554933e-33
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X136.Number of operations, self-reported",52317,0.14135337253949,0.0409168624432538,0.0611563221507126,0.221550422928268,0.000551830580021862
PLA2G15,Phospholipase A2 group XV,Health and medical history,X137.Number of treatments or medications taken,52317,0.570517706258936,0.040124965223863,0.491872774420165,0.649162638097708,1.01660086147513e-45
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X1438.Bread intake,51366,0.00939884334565685,0.00189912534487158,0.00567655766970855,0.0131211290216052,7.50313175842902e-07
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X1458.Cereal intake,50912,-0.0340724699586189,0.040189266781346,-0.112843432850057,0.0446984929328192,0.396556899242705
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X1488.Tea intake,51394,-0.00472076208230552,0.00177268109203727,-0.00819521702269857,-0.00124630714191248,0.00774788508160022
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X1498.Coffee intake,50104,-0.0905017578011313,0.040665633317015,-0.170206399102481,-0.0107971164997818,0.0260557051882978
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X1528.Water intake,50569,-0.0616752559497957,0.0414168326720585,-0.14285224798703,0.019501736087439,0.136463892919045
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1568.Average weekly red wine intake,41481,-0.166821120753228,0.0502817965544933,-0.265373442000035,-0.0682687995064214,0.000909442684698367
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,41484,-0.0669081957596989,0.0503372420812753,-0.165569190238999,0.0317527987196008,0.183800235480733
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1588.Average weekly beer plus cider intake,41506,0.106571823616801,0.0635519171125795,-0.0179899339238546,0.231133581157457,0.0935753999312221
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1598.Average weekly spirits intake,41435,0.088881564245863,0.0563419498649208,-0.0215486574893817,0.199311785981108,0.114690422601723
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1608.Average weekly fortified wine intake,41514,0.100047474091462,0.0863444080970578,-0.0691875657787715,0.269282513961695,0.246593724546275
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1737.Childhood sunburn occasions,45676,0.0277516130104987,0.0480065654799942,-0.0663412553302899,0.121844481351287,0.563216557113019
PLA2G15,Phospholipase A2 group XV,Health and medical history,X1807.Father's age at death,44795,-0.00416937466824628,0.00205615506355889,-0.00819943859282171,-0.000139310743670849,0.0425984676999314
PLA2G15,Phospholipase A2 group XV,Health and medical history,X1845.Mother's age,35314,-0.00684344443212793,0.00457282807491882,-0.0158061874589688,0.00211929859471297,0.134540663104312
PLA2G15,Phospholipase A2 group XV,Health and medical history,X1873.Number of full brothers,51798,0.0300196137055364,0.0390578164087422,-0.0465337064555983,0.106572933866671,0.442140848665911
PLA2G15,Phospholipase A2 group XV,Health and medical history,X1883.Number of full sisters,51805,0.0364614460585232,0.0389423391748996,-0.03986553872428,0.112788430841326,0.349130532013467
PLA2G15,Phospholipase A2 group XV,Physical measures,X20015.Sitting height,52122,-0.000666253288034264,0.00234843894644739,-0.00526919362307115,0.00393668704700262,0.776642039127181
PLA2G15,Phospholipase A2 group XV,Cognitive function,X20016.Fluid intelligence score,33380,-0.108881569018263,0.0641502129036115,-0.234615986309341,0.0168528482728158,0.0896765875823999
PLA2G15,Phospholipase A2 group XV,Cognitive function,X20018.Prospective memory result,33720,0.0933245183608965,0.0843633686872581,-0.0720276842661295,0.258676720987922,0.268659651556637
PLA2G15,Phospholipase A2 group XV,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),33252,0.00345230807696635,0.00329820758576073,-0.00301217879112468,0.00991679494505738,0.29525633377718
PLA2G15,Phospholipase A2 group XV,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),33224,0.0042637135597089,0.00328987036804578,-0.00218443236166083,0.0107118594810786,0.195005230049526
PLA2G15,Phospholipase A2 group XV,Cognitive function,X20023.Mean time to correctly identify matches,52007,0.00875725175175384,0.00191676145835871,0.00500039929337076,0.0125141042101369,4.92708667156288e-06
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#1.Illnesses of father_Heart disease,49064,-0.00163198955934149,0.00392898242644762,-0.00933279511517882,0.00606881599649584,0.677873171368128
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,48634,-0.00108165773970674,0.00850957754318287,-0.0177604297243452,0.0155971142449317,0.898853897176735
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,48604,0.020163132326931,0.0115915643750808,-0.00255633384822747,0.0428825985020894,0.081965564202798
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#12.Illnesses of father_Severe depression,48620,-0.0236829717177645,0.00935973067420392,-0.0420280438392042,-0.00533789959632484,0.0114026413539963
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,48624,-0.015513855657187,0.00701565208705557,-0.0292645337478159,-0.00176317756655809,0.0270229691089924
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#2.Illnesses of father_Stroke,48794,-0.00287675022155072,0.00509234591957396,-0.0128577482239157,0.00710424778081425,0.57213576771134
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#3.Illnesses of father_Lung cancer,48724,-0.00140447433352897,0.00641325883622976,-0.0139744616525393,0.0111655129854814,0.826655454278722
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,48632,0.00933121487470395,0.00818689059036655,-0.00671509068241449,0.0253775204318224,0.254391257729352
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,48782,0.0205223747560983,0.00576398899377086,0.00922495632830743,0.0318197931838892,0.000370930597539491
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#8.Illnesses of father_High blood pressure,48840,-0.00396330755822557,0.00436656328144466,-0.0125217715898571,0.00459515647340596,0.364072573060651
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#9.Illnesses of father_Diabetes,48708,0.00751313164568182,0.00609048658866803,-0.00442422206810751,0.0194504853594712,0.217369615172393
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#1.Illnesses of mother_Heart disease,50450,0.000697941835635316,0.00436915472784763,-0.00786560143094604,0.00926148510221668,0.873084776351384
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,50317,0.00686732992211423,0.00637149209659716,-0.0056207945872162,0.0193554544314447,0.281123561989443
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,50250,-0.0115419151843381,0.0136597947307953,-0.0383151128566968,0.0152312824880207,0.398143664303559
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#12.Illnesses of mother_Severe depression,50287,0.00582560456475792,0.00685591034916424,-0.00761197971960399,0.0192631888491198,0.395488616043082
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#2.Illnesses of mother_Stroke,50382,0.00747598656863573,0.00503060779211277,-0.00238400470390529,0.0173359778411768,0.137264812828444
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,50274,0.0181110814062967,0.00926766068518049,-5.35335366570293e-05,0.0362756963492505,0.0506855553478792
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,50269,0.000722579692943114,0.00824820035969103,-0.0154438930120513,0.0168890523979375,0.930191683256052
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,50298,-0.00790161769108053,0.00654990674705174,-0.0207394349153019,0.00493619953314089,0.227685506592736
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,50316,0.0195229503866755,0.00732356311795278,0.00516876667548801,0.0338771340978629,0.00768594668159404
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,50477,-0.00320653817218134,0.00379356136531074,-0.0106419184481904,0.00422884210382771,0.397974564390845
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#9.Illnesses of mother_Diabetes,50329,0.018514281632199,0.00597382340992271,0.00680558774875045,0.0302229755156475,0.00194229190000658
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,46817,0.00448733565823366,0.00619988577291094,-0.00766444045667179,0.0166391117731391,0.469210129519746
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,46675,-0.00110651528973683,0.0243454807617529,-0.0488236575827726,0.0466106270032989,0.963748604470525
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,46672,0.00179994220675777,0.0250513013154813,-0.0473006083715856,0.0509004927851011,0.942721730835705
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,46737,0.0061203191494697,0.00685790653073449,-0.00732117765076991,0.0195618159497093,0.372162943839654
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,46687,0.00944250584827898,0.0144555573764656,-0.0188903866095935,0.0377753983061515,0.513628050118891
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#2.Illnesses of siblings_Stroke,46701,0.0267765995160827,0.0105517880803146,0.00609509487866616,0.0474581041534993,0.0111671577389003
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,46682,0.00452083954497672,0.0128147066742161,-0.0205959855364868,0.0296376646264402,0.724252784508311
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,46680,0.00476048940626508,0.0124298240335448,-0.0196019656994827,0.0291229445120128,0.701731371906762
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,46699,0.00930682358764388,0.00911569237302081,-0.00855993346347691,0.0271735806387647,0.307281046187623
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,46699,0.013987173776582,0.0110190315976781,-0.00761012815486716,0.0355844757080312,0.204324168314252
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,46890,0.00519802838866572,0.00457338332395283,-0.00376580292628183,0.0141618597036133,0.255724911794178
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,46774,0.0381631166001024,0.00656410850453006,0.0252974639312235,0.0510287692689813,6.18627301509702e-09
PLA2G15,Phospholipase A2 group XV,Mental health,X20127.Neuroticism score,46336,0.146285891694576,0.0412073308436081,0.0655195232411045,0.227052260148048,0.000386044065764683
PLA2G15,Phospholipase A2 group XV,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,33380,-0.0112210357324619,0.0649248813738143,-0.138473803225138,0.116031731760214,0.862788148721391
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X20161.Pack years of smoking,31882,0.0229308665793876,0.00390531687195274,0.0152764455103602,0.030585287648415,4.49908279766654e-09
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,31882,0.0239625682550594,0.00385323522005029,0.0164102272237608,0.031514909286358,5.28026519472261e-10
PLA2G15,Phospholipase A2 group XV,Cognitive function,X20191.Fluid intelligence score,31531,0.0405932174959979,0.0732304949166223,-0.102938552540582,0.184124987532577,0.579376568779537
PLA2G15,Phospholipase A2 group XV,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,31531,0.0509570773009461,0.0746858877456716,-0.0954272626805703,0.197341417282463,0.495080979054752
PLA2G15,Phospholipase A2 group XV,Cognitive function,X20240.Maximum digits remembered correctly,30776,-0.0742119937034777,0.0793192946277326,-0.229677811173834,0.0812538237668782,0.349509349488766
PLA2G15,Phospholipase A2 group XV,Physical measures,X20255.Spirometry QC measure,45893,0.0744339775229827,0.0541190580449599,-0.0316393762451388,0.180507331291104,0.169029708836681
PLA2G15,Phospholipase A2 group XV,Eye measures,X20261.avMSE,30515,-0.00450264970216221,0.00373034151214575,-0.0118141190659679,0.00280881966164346,0.227466070426455
PLA2G15,Phospholipase A2 group XV,Eye measures,X20262.Myopia diagnosis,30515,0.0608200953623304,0.098121129783588,-0.131497319013502,0.253137509738163,0.535381769587955
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X20280.Glucose-lactate,40367,0.02485271185938,0.00243688986799885,0.0200764077181022,0.0296290160006577,2.39162824147477e-24
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X20281.Spectrometer-corrected alanine,40404,0.0287013996438645,0.00232871382687617,0.0241371205431872,0.0332656787445418,9.56239902159754e-35
PLA2G15,Phospholipase A2 group XV,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,33190,-0.00061314379832014,0.0111639427489071,-0.0224944715861781,0.0212681839895378,0.956202022146972
PLA2G15,Phospholipase A2 group XV,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,33187,-0.0113872311033055,0.0209502287672723,-0.0524496794871592,0.0296752172805482,0.586773776556381
PLA2G15,Phospholipase A2 group XV,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),33186,-0.0123033070995459,0.0258271958333658,-0.0629246109329429,0.0383179967338511,0.63382255944271
PLA2G15,Phospholipase A2 group XV,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),33186,-0.00216310366195449,0.0104615657958165,-0.0226677726217548,0.0183415652978458,0.836196866759591
PLA2G15,Phospholipase A2 group XV,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),33186,-0.000227083962775237,0.0207324995139591,-0.040862783010135,0.0404086150845846,0.99126116083796
PLA2G15,Phospholipase A2 group XV,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,33193,0.000809668390264746,0.0254178719882282,-0.0490093607066625,0.050628697487192,0.974588974782779
PLA2G15,Phospholipase A2 group XV,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,33193,0.014007635815229,0.016882130760619,-0.0190813404755842,0.0470966121060422,0.406713261867236
PLA2G15,Phospholipase A2 group XV,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,33193,0.00550584997707843,0.0187108702133218,-0.0311674556410323,0.0421791555951891,0.768566659428622
PLA2G15,Phospholipase A2 group XV,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,33193,-0.0160454202847347,0.030401965381236,-0.0756332724319573,0.043542431862488,0.597668382060424
PLA2G15,Phospholipase A2 group XV,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,33193,0.0099795174849575,0.0367858612775336,-0.0621207706190084,0.0820798055889234,0.786176887339956
PLA2G15,Phospholipase A2 group XV,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,33193,0.0388851636809187,0.0193483724600237,0.000962353659272185,0.0768079737025652,0.0444895757675344
PLA2G15,Phospholipase A2 group XV,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,33193,0.0137981342028346,0.0368004719004087,-0.0583307907219663,0.0859270591276356,0.707710846333942
PLA2G15,Phospholipase A2 group XV,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,33193,0.00704863031441337,0.0254015856433469,-0.0427384775465466,0.0568357381753733,0.781412128607388
PLA2G15,Phospholipase A2 group XV,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),33192,-0.00269539335514278,0.0299193954320456,-0.0613374084019521,0.0559466216916666,0.928218954725401
PLA2G15,Phospholipase A2 group XV,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),33192,0.014306877753884,0.0141143214230167,-0.0133571922352288,0.0419709477429968,0.310781372496128
PLA2G15,Phospholipase A2 group XV,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),33192,-0.0436412407981173,0.0230017957456044,-0.088724760459502,0.00144227886326743,0.05782166390193
PLA2G15,Phospholipase A2 group XV,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,33194,-0.0014887373439632,0.0342131018948221,-0.0685464170578145,0.0655689423698881,0.965293068123754
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20600.Liking for adding salt to foods,35059,0.0668182860966467,0.0607815886453435,-0.0523136276482265,0.18595019984152,0.27165441521184
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20601.Liking for aniseed,35059,0.0331483512601885,0.0609764119823977,-0.0863654162253109,0.152662118745688,0.586710430823621
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20602.Liking for apple juice,35059,0.094513594383136,0.0611607711644459,-0.0253615170991779,0.21438870586545,0.122296242056975
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20603.Liking for apples,35059,-0.149061559360379,0.0626066917537244,-0.271770675197678,-0.0263524435230786,0.0172869973411531
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20604.Liking for asparagus,35059,-0.15919458170223,0.0627301924102082,-0.282145758826238,-0.0362434045782217,0.0111704397595369
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20605.Liking for aubergine,35059,-0.175073270092282,0.0609465723670225,-0.294528551931646,-0.0556179882529182,0.0040795663657388
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20606.Liking for avocados,35059,-0.142415592818396,0.0625493293752869,-0.265012278393958,-0.0198189072428337,0.0228148825707204
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20607.Liking for bacon,35059,-0.160817756847484,0.0614126521351553,-0.281186555032388,-0.0404489586625797,0.00884061430475364
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20608.Liking for baked or steamed fish,35059,-0.212214667871629,0.062374196570307,-0.33446809314943,-0.0899612425938269,0.000670724929617886
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20609.Liking for bananas,35059,0.0186504521890805,0.0629793404917686,-0.104789055174786,0.142089959552947,0.767131997822209
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20610.Liking for barbequed or grilled meat,35059,-0.198455057874338,0.0617133412988804,-0.319413206820143,-0.0774969089285322,0.00130491653844963
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20611.Liking for beef steak,35059,-0.206911785437141,0.0607247257799308,-0.325932247965805,-0.0878913229084766,0.000658353268746221
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20612.Liking for beetroot,35059,-0.07003161017922,0.0631271143261743,-0.193760754258522,0.0536975339000816,0.267293835296276
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20613.Liking for bell pepper,35059,-0.0821476327194779,0.0617143717234448,-0.20310780129743,0.0388125358584739,0.183186701502606
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20614.Liking for bicycling,35059,-0.255220985999085,0.0612012096363143,-0.375175356886261,-0.135266615111908,3.06761994396564e-05
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20615.Liking for biscuits,35059,0.123697832993994,0.0617983885696437,0.00257299139749238,0.244822674590496,0.0453494190843383
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20616.Liking for bitter foods,35059,-0.114634792339413,0.0607012349906773,-0.233609212921141,0.00433962824231419,0.0589850154973505
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20617.Liking for bitter or ale,35059,-0.0910767321940284,0.0633140776533525,-0.215172324394599,0.0330188600065424,0.15032431271664
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20618.Liking for black olives,35059,-0.205177249091309,0.0617791275047644,-0.326264339000648,-0.0840901591819712,0.000899529979085611
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20619.Liking for black pepper,35059,-0.0114346478994165,0.0616904381337804,-0.132347906641626,0.109478610842793,0.852953935790089
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20620.Liking for blue cheese,35059,-0.0919029020246126,0.0610701743599881,-0.211600443770189,0.027794639720964,0.132386339864597
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20621.Liking for bolognese sauce,35059,-0.0813108539770099,0.0618711122780327,-0.202578234041954,0.0399565260879342,0.188808230941642
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20622.Liking for broad beans,35059,-0.0626874481138853,0.0611716029131558,-0.182583789823671,0.0572088935959001,0.305490295694654
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20623.Liking for broccoli,35059,-0.155614441578932,0.0641891413156824,-0.28142515855767,-0.0298037246001947,0.0153540796717698
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20624.Liking for brown rice,35059,-0.250900118788718,0.0623115075854909,-0.37303067365628,-0.128769563921156,5.69966645079928e-05
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20625.Liking for brussel sprouts,35059,-0.0117668451025302,0.0621488085767703,-0.133578509913,0.110044819707939,0.849835146630161
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20626.Liking for burgers (meat),35059,-0.15347574552033,0.0611558035202681,-0.273341120420056,-0.033610370620605,0.012102069459867
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20627.Liking for burn of spicy foods,35059,-0.129429974037553,0.0609545056753643,-0.248900805161267,-0.00995914291383847,0.0337445831214927
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20628.Liking for butter on bread,35059,0.105218889742153,0.0619695720893123,-0.0162414715528989,0.226679251037205,0.0895536996311596
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20629.Liking for butternut squash,35059,-0.229242101282009,0.0613958377186709,-0.349577943210604,-0.108906259353414,0.000189571601484741
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20630.Liking for cabbage,35059,-0.0318994041096213,0.0622160042484812,-0.153842772436644,0.0900439642174019,0.608157721219165
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20631.Liking for cake,35059,0.0278252868827714,0.0614858295257477,-0.0926869389876941,0.148337512753237,0.650883540095055
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20632.Liking for cake icing,35059,0.0842287956012039,0.0608609721873604,-0.0350587098860225,0.20351630108843,0.166401635405425
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20633.Liking for capers,35059,-0.245490210482779,0.0610121423711936,-0.365074009530319,-0.12590641143524,5.77064185029241e-05
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20634.Liking for cauliflower,35059,-0.0140282088867322,0.0629120681626434,-0.137335862485513,0.109279444712049,0.823554430332843
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20635.Liking for cereal or granola bar,35059,-0.00960100605658292,0.0610932020441025,-0.129343682063024,0.110141669949858,0.875126925830238
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20636.Liking for cheesecake,35059,-0.0513109833943772,0.0613231897335451,-0.171504435272126,0.0688824684833713,0.402762935452574
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20637.Liking for cherries,35059,-0.164068267386563,0.0665924293182304,-0.294589428850295,-0.0335471059228316,0.0137642874516316
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20638.Liking for chicken,35059,-0.227664217109827,0.065391691161631,-0.355831931786624,-0.0994965024330298,0.000500535630661229
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20639.Liking for chilli pepper,35059,-0.14013934952224,0.0608633559498363,-0.25943152718392,-0.0208471718605612,0.0213249101987529
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20640.Liking for chips or french fries,35059,0.119149485588873,0.0614531629703172,-0.00129871383294862,0.239597685010695,0.0525440955580719
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20641.Liking for cigarette smoking,35059,-0.0538048562105164,0.102048867616066,-0.253820636738006,0.146210924316973,0.598033811849876
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20642.Liking for cod,35059,-0.16820234969869,0.0632840763980795,-0.292239139438926,-0.0441655599584542,0.00787486864896163
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20643.Liking for coffee with sugar,35059,0.275455247547398,0.0700544650909722,0.138148495969092,0.412761999125703,8.47729358525256e-05
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20644.Liking for coffee without sugar,35059,-0.0863815010863206,0.0629806005439792,-0.20982347815252,0.0370604759798785,0.170230336972715
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20645.Liking for coriander,35059,-0.138245058119601,0.0609271104139799,-0.257662194531002,-0.0188279217082007,0.0232868983596887
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20646.Liking for corn flakes,35059,0.29968189387975,0.0609976042276392,0.180126589593577,0.419237198165922,9.10294490458558e-07
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20647.Liking for cream,35059,0.0382784479093038,0.0611042323983664,-0.0814858475914943,0.158042743410102,0.531036518201029
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20648.Liking for croissant,35059,0.0598215374957025,0.0612178420509915,-0.0601654329242407,0.179808507915646,0.328496800728545
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20649.Liking for cucumber,35059,-0.0397624058088024,0.0622454379692931,-0.161763464228617,0.0822386526110121,0.522966643567693
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20650.Liking for curry,35059,-0.0176116199731679,0.0616899125451799,-0.138523848561721,0.103300608615385,0.775277238945139
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20651.Liking for dairy products,35059,-0.0111825806385695,0.0621446866856245,-0.132986166542394,0.110621005265255,0.85719975575497
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20652.Liking for dark chocolate,35059,-0.162909699079486,0.0622619765696708,-0.284943173156041,-0.0408762250029311,0.00889572421243871
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20653.Liking for diet fizzy drinks,35059,0.126770941499638,0.0642401670974282,0.000860213988678554,0.252681669010597,0.0484770168941505
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20654.Liking for dried fruit,35059,-0.0971838524184822,0.0615458138719126,-0.217813647607431,0.0234459427704666,0.114354675225024
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20655.Liking for eggs,35059,-0.166841685168568,0.0635603170252165,-0.291419906537993,-0.042263463799144,0.00867899649426314
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20656.Liking for exercising alone,35059,-0.200925706404938,0.0607933513206482,-0.320080674993409,-0.081770737816468,0.000952711533435957
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20657.Liking for exercising with others,35059,-0.165586670834823,0.06146643709026,-0.286060887531733,-0.0451124541379133,0.0070724849585348
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20658.Liking for extra virgin olive oil,35059,-0.152185266144761,0.0625452550588519,-0.274773966060111,-0.0295965662294111,0.0149823540905589
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20659.Liking for fatty foods,35059,-0.0358385138046103,0.0611967045572485,-0.155784054736817,0.0841070271275967,0.558137886818163
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20660.Liking for fresh tomatoes,35059,0.0203075292237513,0.0674850304374024,-0.111963130433557,0.15257818888106,0.763482149436083
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20661.Liking for fried chicken,35059,-0.0906685549531834,0.060854097964628,-0.209942586963854,0.0286054770574874,0.136271498870098
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20662.Liking for fried or battered fish,35059,-0.0121746348643901,0.0618413366086084,-0.133383654617263,0.109034384888482,0.843933919921092
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20663.Liking for fruit,35059,-0.0931916256392593,0.0709790373776992,-0.23231053889955,0.0459272876210311,0.18922965643002
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20664.Liking for garlic,35059,-0.103665650682759,0.0627140199361608,-0.226585129757635,0.0192538283921159,0.0983625091439857
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20665.Liking for gherkins,35059,-0.107755843018341,0.0609157368658491,-0.227150687275405,0.0116390012387235,0.0769338522671592
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20666.Liking for globe artichoke,35059,-0.0480061159548677,0.0612971705476364,-0.168148570228235,0.0721363383184996,0.433544685223356
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20667.Liking for goat's cheese,35059,-0.192629371898323,0.061375615435586,-0.312925578152072,-0.0723331656445746,0.00170261806439227
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20668.Liking for going to a cafe,35059,-0.0147580165776457,0.062489199052924,-0.137236846721377,0.107720813566085,0.813306036293506
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20669.Liking for going to the gym,35059,-0.128864579307039,0.0613394246475354,-0.249089851616208,-0.00863930699786927,0.0356781980075446
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20670.Liking for going to the pub,35059,-0.145352120203595,0.0617628369995414,-0.266407280722696,-0.0242969596844935,0.0186212135198342
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20671.Liking for grapefruit,35059,-0.0146071984896559,0.0614542043557377,-0.135057439026902,0.10584304204759,0.812124258762729
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20672.Liking for green olives,35059,-0.176925558378308,0.0614200331513042,-0.297308823354864,-0.0565422934017514,0.00397735265683104
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20673.Liking for haddock,35059,-0.16663327440562,0.0628756562725104,-0.28986956069974,-0.0433969881114993,0.00805628178716425
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20674.Liking for ham,35059,-0.151946289298308,0.0615904931318407,-0.272663655836716,-0.0312289227599002,0.0136391585218042
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20675.Liking for hard cheese,35059,-0.0560603743753112,0.0624766884658832,-0.178514683768442,0.0663939350178199,0.369578882160404
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20676.Liking for herring,35059,-0.206086656390446,0.0608573766973874,-0.325367114717326,-0.0868061980635668,0.000710766560484505
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20677.Liking for honey,35059,-0.116022698087395,0.0615630098615153,-0.236686197415965,0.0046408012411749,0.0595088993405503
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20678.Liking for horseradish or wasabi,35059,-0.214692785728924,0.060927488242835,-0.33411066268488,-0.0952749087729673,0.000427290576160292
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20679.Liking for ice cream,35059,0.0079345869751666,0.0611835688120274,-0.111985207896407,0.12785438184674,0.896818165336341
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20680.Liking for jam,35059,0.159594307705715,0.0611747797770774,0.0396917393426428,0.279496876068786,0.00909812090404577
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20681.Liking for kiwi fruit,35059,-0.0522177756983665,0.062576814209193,-0.174868331548385,0.0704327801516518,0.404041281633407
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20682.Liking for lager,35059,-0.130261796082416,0.0621207436833767,-0.252018453701835,-0.00850513846299805,0.0360249142923998
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20683.Liking for lamb,35059,-0.244503085492118,0.0621341610618498,-0.366286041173344,-0.122720129810892,8.36990140277423e-05
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20684.Liking for lemons,35059,-0.0696454542280221,0.0619508477783681,-0.191069115873624,0.0517782074175794,0.260951521482003
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20685.Liking for lentils or beans,35059,-0.113448014709466,0.0618734514094426,-0.234719979471973,0.0078239500530414,0.0667489738944869
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20686.Liking for liver,35059,-0.235193568258933,0.0610952709524998,-0.354940299325833,-0.115446837192034,0.000118996498217171
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20687.Liking for mackerel,35059,-0.269259070211189,0.0610878822932762,-0.38899131950601,-0.149526820916368,1.05486132283809e-05
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20688.Liking for marzipan,35059,0.0368216734419681,0.0607814033711484,-0.0823098771654828,0.155953224049419,0.544657273188808
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20689.Liking for mayonnaise,35059,-0.0315529238796197,0.0613282355086952,-0.151756265476662,0.0886504177174229,0.606918355100322
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20690.Liking for melon,35059,0.014361679051925,0.0641607822240061,-0.111393454107127,0.140116812210977,0.822886972957692
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20691.Liking for milk chocolate,35059,0.0220112053311599,0.0618050129521529,-0.0991266200550597,0.14314903071738,0.721743199364305
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20692.Liking for mushrooms,35059,-0.129032464875295,0.0643370405291017,-0.255133064312334,-0.00293186543825566,0.0449274750461968
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20694.Liking for orange juice,35059,0.288551122347347,0.0614662799375952,0.168077213669661,0.409025031025034,2.70661269721685e-06
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20695.Liking for oranges,35059,-0.0829910203123698,0.0621388142327094,-0.20478309620848,0.0388010555837406,0.181717047366794
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20696.Liking for pasta,35059,-0.0121465761831039,0.0614880947641243,-0.132663241920788,0.10837008955458,0.843405997639691
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20697.Liking for pears,35059,0.120544611832633,0.0629155734133258,-0.00276991205748595,0.243859135722751,0.055395260618108
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20698.Liking for pizza,35059,-0.0653580040317356,0.0615129337110963,-0.185923354105484,0.0552073460420131,0.28802919168434
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20699.Liking for plain yogurt,35059,-0.280610596958559,0.0620650423776962,-0.402258080018843,-0.158963113898274,6.21471223365825e-06
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20700.Liking for plums,35059,-0.0104346050007166,0.0631179997383688,-0.13414588448792,0.113276674486486,0.86869605291237
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20701.Liking for pollock,35059,-0.1910853757781,0.0608723999876111,-0.310395279753818,-0.0717754718023823,0.00169924939961644
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20702.Liking for pork chop,35059,-0.264334862610574,0.0612616069271054,-0.384407612187701,-0.144262113033448,1.61157184343218e-05
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20703.Liking for porridge,35059,-0.0204333347794054,0.0628036562042191,-0.143528500939675,0.102661831380864,0.744920624589413
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20704.Liking for potato crisps,35059,0.14067228048548,0.061206384556507,0.0207077667547263,0.260636794216234,0.0215625636563988
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20705.Liking for potatoes,35059,0.132936055661346,0.0627369674117262,0.00997159953436232,0.255900511788329,0.0341184805792475
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20706.Liking for prawns,35059,-0.120376745451167,0.0626158224076302,-0.243103757370123,0.00235026646778794,0.0545740093921732
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20707.Liking for raw carrots,35059,-0.104016191831545,0.0620205482420535,-0.22557646638597,0.0175440827228795,0.093547594678738
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20708.Liking for red meat,35059,-0.242099576812079,0.0608557368552105,-0.361376821048291,-0.122822332575866,6.98852374742415e-05
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20709.Liking for red wine,35059,-0.242823755608805,0.0614431469151902,-0.363252323562578,-0.122395187655032,7.80014266532032e-05
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,35059,0.169907516846183,0.0650894285018611,0.0423322369825355,0.297482796709831,0.00905715037233396
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20711.Liking for roast chicken,35059,-0.236966103343472,0.0655083782263051,-0.36536252466703,-0.108569682019914,0.000299029513325229
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20712.Liking for salad dressing,35059,-0.0655105098684119,0.0617907647011192,-0.186620408682606,0.0555993889457818,0.289078215377978
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20713.Liking for salad leaves,35059,-0.147809791966287,0.0637726959855127,-0.272804276097892,-0.0228153078346825,0.0204813255148317
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20714.Liking for salami,35059,-0.21954306998632,0.0612671272735743,-0.339626639442525,-0.0994595005301139,0.000340705675418231
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20715.Liking for salmon,35059,-0.297815905457404,0.0657950977538434,-0.426774297054937,-0.16885751385987,6.06465225516013e-06
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20716.Liking for salty foods,35059,0.102973654115909,0.060422992062324,-0.0154554103262459,0.221402718558064,0.0883705970112822
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20717.Liking for salty pretzels,35059,-0.0236063246448186,0.0614635017348543,-0.144074788045133,0.0968621387554957,0.70093381864067
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20718.Liking for sardines,35059,-0.193114402704755,0.0607296388553519,-0.312144494861245,-0.0740843105482656,0.00147748104669191
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20719.Liking for sausages (meat),35059,-0.131257753317186,0.0613467263688948,-0.25149733700022,-0.0110181696341526,0.0324094870612513
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20720.Liking for savoury biscuits,35059,-0.016024841297526,0.0614660500421429,-0.136498299380126,0.104448616785074,0.79432087546707
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20721.Liking for shellfish (other than prawns),35059,-0.200879524801356,0.0610156109476684,-0.320470122258786,-0.0812889273439263,0.000997093826893935
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20722.Liking for skimmed milk,35059,-0.106217529595719,0.0613845280953502,-0.226531204662605,0.0140961454711677,0.0835945113307134
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20723.Liking for smoked fish,35059,-0.194018460476303,0.0613345160278301,-0.31423411189085,-0.0738028090617561,0.00156440840208798
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20724.Liking for soft cheese,35059,-0.0387593003506136,0.0611938374396989,-0.158699221732423,0.0811806210311962,0.526495481620396
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20725.Liking for soy sauce,35059,-0.094621386209721,0.0614198720979335,-0.215004335521671,0.0257615631022287,0.123452226258327
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20726.Liking for soya milk,35059,-0.0456445302298298,0.0605284511983174,-0.164280294578532,0.0729912341188723,0.450805681815394
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20727.Liking for spicy foods,35059,-0.0911113039324247,0.0609854054039503,-0.210642698524167,0.0284200906593179,0.135209212167909
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20728.Liking for spinach,35059,-0.227733775632645,0.0625791747886458,-0.350388958218391,-0.105078593046899,0.000274861066365577
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20729.Liking for spirits,35059,-0.080373573790685,0.0611696024395642,-0.200265994572231,0.0395188469908608,0.188892710476667
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20730.Liking for strawberries,35059,-0.0367876975910424,0.069737938822685,-0.173474057683505,0.0998986625014202,0.597848152587878
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20731.Liking for sweet coffee house drinks,35059,0.150743091272391,0.0635396392420367,0.0262053983579989,0.275280784186783,0.0176894508296614
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20732.Liking for sweet foods,35059,0.141055704635771,0.0609747917727939,0.0215451127610952,0.260566296510447,0.0207227451290326
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20733.Liking for taking the stairs,35059,-0.259060351830303,0.0630445763303405,-0.38262772143777,-0.135492982222835,4.00087011519938e-05
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20734.Liking for tea with sugar,35059,0.187083894192827,0.0817303598624579,0.0268923888624099,0.347275399523245,0.0220967252929076
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20735.Liking for tea without sugar,35059,-0.159880632229429,0.0660478030468004,-0.289334326201158,-0.0304269382577007,0.0155081782962012
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20736.Liking for tomato ketchup,35059,0.100729036514708,0.0607973325102953,-0.0184337352054706,0.219891808234887,0.0975894647977439
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20737.Liking for tinned tuna,35059,-0.152366887127106,0.0621186611367468,-0.274119462955129,-0.030614311299082,0.0141894935231884
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20738.Liking for turnip (white),35059,-0.125893535149024,0.0611637907403383,-0.245774565000087,-0.00601250529796096,0.0395855734823089
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20739.Liking for vegetables,35059,-0.0933622118044228,0.071071641932196,-0.232662629991527,0.0459382063826812,0.188997427456759
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20740.Liking for vinegar,35059,-0.0304305096360707,0.0612319629308198,-0.150445156980477,0.089584137708336,0.619219813113638
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20741.Liking for watching television,35059,-0.00439932437795184,0.0615942432551324,-0.125124041158011,0.116325392402108,0.943061435301539
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20742.Liking for whisky,35059,-0.0421829275780259,0.0651382384188694,-0.16985387487901,0.085488019722958,0.517263640511485
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20743.Liking for white bread,35059,0.19683884038903,0.0608974080462624,0.0774799206183558,0.316197760159705,0.00123172481532161
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20744.Liking for white rice,35059,0.0212301334256132,0.0611906395150018,-0.0987035200237904,0.141163786875017,0.728635267219096
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20745.Liking for white wine,35059,-0.199368908679258,0.0612723320458123,-0.319462679489051,-0.0792751378694662,0.00114222712710094
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,35059,-0.116779729387887,0.0620413494918497,-0.238380774391913,0.00482131561613808,0.0598242057753377
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20747.Liking for whole milk,35059,-0.00554294037603376,0.0611675392229575,-0.12543131725303,0.114345436500963,0.927797057946107
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20748.Liking for wholemeal bread,35059,-0.149535502639646,0.0647253977792779,-0.27639728228703,-0.0226737229922611,0.0208903060423993
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20749.Liking for working up a sweat,35059,-0.192430325892311,0.0608689086482562,-0.311733386842893,-0.0731272649417287,0.00157460790761653
PLA2G15,Phospholipase A2 group XV,Physical measures,X21001.Body mass index (BMI),52215,-0.0523585401083889,0.00681259242212636,-0.0657112212557566,-0.0390058589610213,1.57358485337706e-14
PLA2G15,Phospholipase A2 group XV,Physical measures,X21002.Weight,52223,-0.00630776147608939,0.00421755609106817,-0.014574171414583,0.00195864846240421,0.134770239292824
PLA2G15,Phospholipase A2 group XV,Physical measures,X21021.Pulse wave Arterial Stiffness index,33611,0.014387912350139,0.00305321384657487,0.00840361321085224,0.0203722114894257,2.48445074592817e-06
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,34479,0.117345580291778,0.0640358658981514,-0.00816471686859878,0.242855877452155,0.0669069499308298
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,34495,0.0390375320086375,0.0665726252368245,-0.0914448134555385,0.169519877472814,0.557626541795383
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,34496,-0.118601008070042,0.0667289148409284,-0.249389681158262,0.0121876650181777,0.0755400192656955
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21040.Satisfaction with bowel habits,34446,0.0241718919020115,0.0621170200682729,-0.0975774674318034,0.145921251235826,0.697184756849792
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,34427,0.0865568045430615,0.0648557014631904,-0.0405603703247917,0.213673979410915,0.182035841886169
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21042.Greatest number of times bowels opened per day,34440,0.116663894308862,0.0664793246076602,-0.0136355819221521,0.246963370539876,0.0793088054354081
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21043.Least number of times bowels opened per week,34348,0.0621626189729731,0.065797279270486,-0.0668000483971795,0.191125286343126,0.344804629542563
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21044.Average number of times bowels opened per day,34401,0.304763580454737,0.0760044210447321,0.155794915207062,0.453732245702412,6.12109869858446e-05
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,34499,-0.0910693564028445,0.0675101128418399,-0.223389177572851,0.0412504647671617,0.177375867303421
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,34493,-0.0235003145405576,0.0677227094864811,-0.156236825134061,0.109236196052945,0.728592664062289
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,34496,0.145935825373516,0.0792927608817223,-0.00947798595466012,0.301349636701691,0.0657289789788447
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,34496,-0.0439029778049758,0.0708596477789245,-0.182787887451668,0.0949819318417163,0.535550649038119
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,34493,-0.00144535296475586,0.104451370775849,-0.206170039685421,0.203279333755909,0.98895984526663
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,34494,-0.173087067964017,0.0773061760259789,-0.324607172974935,-0.0215669629530979,0.0251789590080287
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,34494,-0.0388381090721531,0.195668750654979,-0.422348860355912,0.344672642211606,0.842666451074271
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,34498,0.00374999293364695,0.0732139656144246,-0.139749379670625,0.147249365537919,0.959151520659171
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,34497,-0.222025679478294,0.0771010837393294,-0.37314380360738,-0.0709075553492087,0.00398932951385549
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,34230,0.0837551622214757,0.0688746752033461,-0.0512392011770827,0.218749525620034,0.223994610196331
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,34494,-0.0771564356464204,0.0697715145883319,-0.213908604239551,0.0595957329467101,0.268820386985486
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,34496,-0.353756717235818,0.0912587405463489,-0.532623848706662,-0.174889585764975,0.000106681914968885
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,34498,-0.305732068955268,0.067500705252467,-0.438033451250103,-0.173430686660433,5.98569353032844e-06
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,34496,0.0128759171003326,0.0676613800485021,-0.119740387794731,0.145492221995397,0.849078403896559
PLA2G15,Phospholipase A2 group XV,Working and living environment,X21100.Water hardness (USGS classification),52075,-0.0313119715115485,0.039411730167702,-0.108558962640244,0.0459350196171473,0.426920804563353
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X2139.Age first had sexual intercourse,48385,-0.00315794861520728,0.00214718973107153,-0.00736644048810748,0.00105054325769292,0.141375751415146
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2149.Lifetime number of sexual partners,46838,-0.10138895592918,0.0442966144046675,-0.188210320162328,-0.0145675916960318,0.0220964859826763
PLA2G15,Phospholipase A2 group XV,Physical activities,X22032.IPAQ activity group,45929,-0.277643230599475,0.0447222076156448,-0.365298757526138,-0.189987703672811,5.45861390632971e-10
PLA2G15,Phospholipase A2 group XV,Physical activities,X22033.Summed days activity,46615,-0.0125806810071563,0.00203543690564596,-0.0165701373422224,-0.00859122467209021,6.48796124371373e-10
PLA2G15,Phospholipase A2 group XV,Physical activities,X22034.Summed minutes activity,45929,-0.0125445457610201,0.00205057263878861,-0.0165636681330458,-0.00852542338899443,9.66490127605968e-10
PLA2G15,Phospholipase A2 group XV,Physical activities,X22037.MET minutes per week for walking,44894,-0.00893029058432751,0.00207891878216523,-0.0130049713973714,-0.00485560977128365,1.74992462854491e-05
PLA2G15,Phospholipase A2 group XV,Physical activities,X22038.MET minutes per week for moderate activity,45929,-0.00884326839876713,0.00202583881829597,-0.0128139124826272,-0.00487262431490703,1.275775371443e-05
PLA2G15,Phospholipase A2 group XV,Physical activities,X22039.MET minutes per week for vigorous activity,45929,-0.290733621722222,0.0449732208958194,-0.378881134678028,-0.202586108766416,1.03754229413043e-10
PLA2G15,Phospholipase A2 group XV,Physical activities,X22040.Summed MET minutes per week for all activity,44894,-0.0135563699366113,0.00211713067522529,-0.0177059460600529,-0.00940679381316972,1.55483802987948e-10
PLA2G15,Phospholipase A2 group XV,Eye measures,X2217.Age started wearing glasses or contact lenses,48406,-0.00539685171904193,0.00194861458187066,-0.00921613629950844,-0.00157756713857543,0.00561711247332907
PLA2G15,Phospholipase A2 group XV,Working and living environment,X22501.Year ended full time education,31392,-0.0183597186769444,0.00885011874180578,-0.0357059514108837,-0.00101348594300506,0.038068127435953
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X22506.Tobacco smoking,31348,0.116263574710391,0.169224175401208,-0.215415809075976,0.447942958496759,0.492081386944576
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,50415,-0.254888855337414,0.0926841260880403,-0.436549742469973,-0.0732279682048552,0.00596217713980281
PLA2G15,Phospholipase A2 group XV,Physical measures,X23098.Weight,51792,-0.00569944835603657,0.00423758283223044,-0.0140051107072082,0.00260621399513509,0.178644054069812
PLA2G15,Phospholipase A2 group XV,Physical measures,X23099.Body fat percentage,51793,0.00381369940080137,0.00434802110938747,-0.00470842197359807,0.0123358207752008,0.380433775222285
PLA2G15,Phospholipase A2 group XV,Physical measures,X23100.Whole body fat mass,51784,-0.00169309264750586,0.00416638528038783,-0.009859207797066,0.00647302250205428,0.684474176774216
PLA2G15,Phospholipase A2 group XV,Physical measures,X23101.Whole body fat-free mass,51792,-0.0118754364263269,0.00349154424829468,-0.0187188631529844,-0.00503200969966927,0.00067186975999225
PLA2G15,Phospholipase A2 group XV,Physical measures,X23102.Whole body water mass,51792,-0.0115670680181068,0.00350385901976959,-0.0184346316968552,-0.00469950433935837,0.000963829152927177
PLA2G15,Phospholipase A2 group XV,Physical measures,X23104.Body mass index (BMI),51792,-0.0531037736881554,0.00688004837327054,-0.0665886684997657,-0.0396188788765452,1.21698455555722e-14
PLA2G15,Phospholipase A2 group XV,Physical measures,X23105.Basal metabolic rate,51790,-0.0119726796693333,0.00380650094124181,-0.0194334215141672,-0.0045119378244993,0.00166080598778136
PLA2G15,Phospholipase A2 group XV,Physical measures,X23106.Impedance of whole body,51786,0.0139389816084685,0.00285110075239397,0.00835082413377632,0.0195271390831607,1.01933065723215e-06
PLA2G15,Phospholipase A2 group XV,Physical measures,X23107.Impedance of leg (right),51789,0.00999116773865344,0.00233495832031733,0.00541464943083147,0.0145676860464754,1.88416001560465e-05
PLA2G15,Phospholipase A2 group XV,Physical measures,X23108.Impedance of leg (left),51788,0.00895328152212938,0.00231196692973866,0.00442182633984161,0.0134847367044172,0.000107939036276411
PLA2G15,Phospholipase A2 group XV,Physical measures,X23109.Impedance of arm (right),51779,0.0146013918013643,0.00285567786939225,0.00900426317735549,0.0201985204253731,3.19036342655619e-07
PLA2G15,Phospholipase A2 group XV,Physical measures,X23110.Impedance of arm (left),51787,0.0151131661994031,0.00286487684076452,0.00949800759150464,0.0207283248073015,1.33526849546825e-07
PLA2G15,Phospholipase A2 group XV,Physical measures,X23111.Leg fat percentage (right),51788,0.0345707047183205,0.00686841179171927,0.0211086176065507,0.0480327918300903,4.85192106963359e-07
PLA2G15,Phospholipase A2 group XV,Physical measures,X23112.Leg fat mass (right),51787,-0.0084760791215063,0.00788403114546613,-0.0239287801666199,0.00697662192360731,0.282341876888353
PLA2G15,Phospholipase A2 group XV,Physical measures,X23113.Leg fat-free mass (right),51787,-0.00799718999863959,0.00354767738656564,-0.0149506376763082,-0.00104374232097093,0.0241911959479746
PLA2G15,Phospholipase A2 group XV,Physical measures,X23114.Leg predicted mass (right),51786,-0.00768331813698849,0.00356161765612302,-0.0146640887429896,-0.000702547530987378,0.0309944743838957
PLA2G15,Phospholipase A2 group XV,Physical measures,X23115.Leg fat percentage (left),51783,0.0349395260366993,0.00708644161641671,0.0210501004685226,0.0488289516048761,8.25102048946057e-07
PLA2G15,Phospholipase A2 group XV,Physical measures,X23116.Leg fat mass (left),51783,-0.00873398754621713,0.00791371363632916,-0.0242448662734223,0.00677689118098802,0.269753750562383
PLA2G15,Phospholipase A2 group XV,Physical measures,X23117.Leg fat-free mass (left),51781,-0.00759552588122198,0.00363963282032724,-0.0147292062090634,-0.000461845553380595,0.0369070108592295
PLA2G15,Phospholipase A2 group XV,Physical measures,X23118.Leg predicted mass (left),51780,-0.008252507501856,0.00365430311781029,-0.0154149416127642,-0.00109007339094783,0.0239349031835776
PLA2G15,Phospholipase A2 group XV,Physical measures,X23119.Arm fat percentage (right),51780,-0.0071501857952368,0.00483291565013189,-0.0166227004694953,0.00232232887902169,0.139024497630167
PLA2G15,Phospholipase A2 group XV,Physical measures,X23120.Arm fat mass (right),51776,-0.0144457326713259,0.0043500609637839,-0.0229718521603424,-0.00591961318230949,0.000898736876338942
PLA2G15,Phospholipase A2 group XV,Physical measures,X23121.Arm fat-free mass (right),51778,-0.0138477082245835,0.00339553799901783,-0.0205029627026584,-0.00719245374650852,4.55127901322693e-05
PLA2G15,Phospholipase A2 group XV,Physical measures,X23122.Arm predicted mass (right),51777,-0.0135425174333743,0.00339449527930373,-0.0201957281808096,-0.00688930668593898,6.63705163529051e-05
PLA2G15,Phospholipase A2 group XV,Physical measures,X23123.Arm fat percentage (left),51774,-0.00648395477059783,0.00541909476648215,-0.0171053805129028,0.00413747097170718,0.231511313743663
PLA2G15,Phospholipase A2 group XV,Physical measures,X23124.Arm fat mass (left),51773,-0.016937944196648,0.00446033253433635,-0.0256801959639473,-0.00819569242934875,0.000146501202790762
PLA2G15,Phospholipase A2 group XV,Physical measures,X23125.Arm fat-free mass (left),51773,-0.0139517843796434,0.00365966581914281,-0.0211247293851633,-0.00677883937412344,0.000137975623478695
PLA2G15,Phospholipase A2 group XV,Physical measures,X23126.Arm predicted mass (left),51771,-0.0145450459694896,0.00366404610727727,-0.021726576339753,-0.00736351559922612,7.21569426934628e-05
PLA2G15,Phospholipase A2 group XV,Physical measures,X23127.Trunk fat percentage,51769,0.00330895448717255,0.00274852637445908,-0.00207815720676724,0.00869606618111235,0.228638159452336
PLA2G15,Phospholipase A2 group XV,Physical measures,X23128.Trunk fat mass,51765,0.00326115247008216,0.00316745907623568,-0.00294706731933977,0.00946937225950409,0.30321633166871
PLA2G15,Phospholipase A2 group XV,Physical measures,X23129.Trunk fat-free mass,51759,-0.0116268586723486,0.00325996118019682,-0.0180163825855343,-0.0052373347591628,0.000362311545691439
PLA2G15,Phospholipase A2 group XV,Physical measures,X23130.Trunk predicted mass,51756,-0.0115758946357239,0.00326542241524264,-0.0179761225695995,-0.0051756667018483,0.000393282081052576
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23400.Total Cholesterol,40411,-0.00879456773222783,0.00243019661450066,-0.0135577530966491,-0.00403138236780654,0.000296805724129435
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,40411,-0.000282818144066115,0.00235274654420277,-0.00489420137070354,0.00432856508257131,0.904320167412038
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",40411,0.00630201615562156,0.00234918132101368,0.00169762076643474,0.0109064115448084,0.00731180337168861
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23403.VLDL Cholesterol,40411,0.0181836262113623,0.00230064692195235,0.0136743582443357,0.0226928941783889,2.88320921524756e-15
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23404.Clinical LDL Cholesterol,40411,-0.0092523649987402,0.00235264958968692,-0.0138635581945266,-0.00464117180295384,8.43372612179458e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23405.LDL Cholesterol,40411,-0.00647402756547883,0.00235294983619085,-0.0110858092444129,-0.00186224588654477,0.00593987225018546
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23406.HDL Cholesterol,40411,-0.0329190678609593,0.00269771198002846,-0.0382065833418151,-0.0276315523801035,4.27200458602075e-34
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23407.Total Triglycerides,40411,0.0403690496093039,0.0024725008339002,0.0355229479748595,0.0452151512437483,1.91644747492345e-59
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23408.Triglycerides in VLDL,40411,0.0351090742052181,0.00247860647826317,0.0302510055078223,0.0399671429026139,2.84363602482266e-45
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23409.Triglycerides in LDL,40411,0.0461069276692699,0.00245820911479624,0.0412888378042692,0.0509250175342705,1.17465784125091e-77
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23410.Triglycerides in HDL,40411,0.0496838102022197,0.00231699861947089,0.0451424929080568,0.0542251274963827,1.38286581249781e-100
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,40411,0.00410732217565869,0.0024774844917007,-0.000748547428074676,0.00896319177939205,0.0973654028150924
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23412.Phospholipids in VLDL,40411,0.0276975449948628,0.00236312845719391,0.0230658132187628,0.0323292767709629,1.3451752195856e-31
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23413.Phospholipids in LDL,40411,-0.00460585431800557,0.00233605698361996,-0.00918452600590069,-2.71826301104505e-05,0.0486684060279192
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23414.Phospholipids in HDL,40411,-0.0103181086186491,0.00263026228961238,-0.0154734227062894,-0.00516279453100887,8.78762921084768e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23415.Total Esterified Cholesterol,40411,-0.0109537256809283,0.00243730908642905,-0.0157308514903292,-0.00617659987152733,7.03268718679406e-06
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,40411,0.0143514257910763,0.00228868635747641,0.00986560053042256,0.0188372510517301,3.68922150804416e-10
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23417.Cholesteryl Esters in LDL,40411,-0.00333850295924833,0.0023488364534144,-0.00794222240794056,0.00126521648944389,0.155236520728547
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23418.Cholesteryl Esters in HDL,40411,-0.0362728418958291,0.00267625013073536,-0.0415182921520704,-0.0310273916395878,1.28192528045263e-41
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23419.Total Free Cholesterol,40411,-0.00337482694146012,0.00241064677539644,-0.00809969462123714,0.0013500407383169,0.161542514643001
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23420.Free Cholesterol in VLDL,40411,0.0230790319560197,0.00233875219494413,0.0184950776539292,0.0276629862581102,6.65688917366621e-23
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23421.Free Cholesterol in LDL,40411,-0.014977055656383,0.00236939871515667,-0.01962107713809,-0.0103330341746759,2.66712898411298e-10
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23422.Free Cholesterol in HDL,40411,-0.019311297914941,0.00271917312860341,-0.0246408772470037,-0.0139817185828783,1.28244944970558e-12
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,40411,0.00910532534740875,0.00242121147250264,0.00435975086130358,0.0138508998335139,0.000170078559891608
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23424.Total Lipids in VLDL,40411,0.0301942256571391,0.00240921912185965,0.0254721561782942,0.0349162951359841,7.28739791022501e-36
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23425.Total Lipids in LDL,40411,-0.00290338129586352,0.00234906311244059,-0.00750754499624707,0.00170078240452004,0.216486362147399
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23426.Total Lipids in HDL,40411,-0.0164673220312818,0.0026593805955202,-0.0216797079985014,-0.0112549360640622,6.07960364848059e-10
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,40411,-0.0128347057274214,0.00248801690197286,-0.0177112188552882,-0.00795819259955459,2.51770445285379e-07
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23428.Concentration of VLDL Particles,40411,0.0248924916696593,0.00233017014342083,0.0203253581885544,0.0294596251507641,1.50809746661087e-26
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23429.Concentration of LDL Particles,40411,-0.000757118215655875,0.00233093338308861,-0.00532574764650955,0.0038115112151978,0.745326618752167
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23430.Concentration of HDL Particles,40411,-0.0142141444291243,0.00249277106852122,-0.0190999757234258,-0.00932831313482267,1.20402347890147e-08
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23431.Average Diameter for VLDL Particles,40411,0.0252884694559093,0.00262354541492655,0.0201463204426533,0.0304306184691653,6.27630824548582e-22
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23432.Average Diameter for LDL Particles,40411,-0.0344011553855239,0.00239226666943893,-0.0390899980576242,-0.0297123127134236,1.34808451732607e-46
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23433.Average Diameter for HDL Particles,40411,-0.0266998553399243,0.00284165257089776,-0.0322694943788839,-0.0211302163009646,6.42509684052484e-21
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23434.Phosphoglycerides,40396,0.00750541806643888,0.00248881326396717,0.00262734406906323,0.0123834920638145,0.00256823210423929
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,40396,0.044500027108732,0.00261308043529898,0.039378389455546,0.0496216647619179,1.8360247517582e-64
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23436.Total Cholines,40396,0.00291989805175924,0.00249504380164642,-0.00197038779946774,0.00781018390298622,0.241906091191979
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23437.Phosphatidylcholines,40396,0.00538331164798205,0.0024959722458086,0.000491206046197192,0.0102754172497669,0.0310361912937121
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23438.Sphingomyelins,40395,-0.0106350302482754,0.00250792363266167,-0.0155505605682922,-0.0057194999282585,2.24207558203175e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23439.Apolipoprotein B,40411,0.00258035611213106,0.00232985522815961,-0.00198616013506178,0.0071468723593239,0.2680868172717
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23440.Apolipoprotein A1,40411,-0.0115617344333187,0.00257885687515681,-0.0166162939086261,-0.00650717495801139,7.40168009669019e-06
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,40411,0.00776525761314606,0.00235087718618747,0.00315753832821861,0.0123729768980735,0.000958216574476954
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23442.Total Fatty Acids,40396,0.0220327066660283,0.00248902623713965,0.0171542152412346,0.026911198090822,9.49056928848978e-19
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23443.Degree of Unsaturation,40396,-0.0740382679362896,0.00254994451023966,-0.0790361591763594,-0.0690403766962199,1.14913940560556e-180
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23444.Omega-3 Fatty Acids,40396,-0.025860786469625,0.00243622682415697,-0.0306357910449726,-0.0210857818942773,3.10174165589529e-26
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23445.Omega-6 Fatty Acids,40396,-0.00108566843984962,0.00241114858170053,-0.00581151965998267,0.00364018278028342,0.652521720106169
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,40396,-0.00725984416119035,0.00243202268521054,-0.012026608624203,-0.00249307969817769,0.00283910675251304
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23447.Monounsaturated Fatty Acids,40396,0.0361077308126222,0.00254511398563854,0.0311193074007706,0.0410961542244737,2.08105218404506e-45
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23448.Saturated Fatty Acids,40396,0.0341927940122736,0.00253330160987704,0.0292275228569146,0.0391580651676326,2.73337161831496e-41
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23449.Linoleic Acid,40396,0.00308966026957873,0.00238720357261478,-0.00158925873274624,0.0077685792719037,0.195594637576641
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23450.Docosahexaenoic Acid,40396,-0.039336909927329,0.00255188008786898,-0.0443385948995522,-0.0343352249551058,3.14734194920788e-53
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,40396,-0.0439037327492042,0.002418053263363,-0.0486431171453957,-0.0391643483530127,6.17282254548099e-73
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,40396,-0.052365343585877,0.00269325108591638,-0.0576441157142731,-0.0470865714574808,3.05849535680558e-83
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,40396,-0.0745233417302999,0.00267399748055558,-0.0797643767921888,-0.0692823066684109,6.08356604787035e-167
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,40396,0.0537692541047635,0.00266340913700982,0.0485489721962243,0.0589895360133028,1.63230250239927e-89
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,40396,0.0580895975870495,0.00250445385645991,0.0531808680283881,0.0629983271457109,4.4517618482219e-117
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,40396,-0.0322190059169128,0.00260722674184746,-0.0373291703309338,-0.0271088415028918,6.40581991974642e-35
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,40396,-0.0555988012911856,0.00256589823904236,-0.0606279618397086,-0.0505696407426625,1.22842370327953e-102
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,40396,-0.0656130490428982,0.00267613308909889,-0.070858269897532,-0.0603678281882644,2.44119137162254e-130
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,40394,0.0283557568404632,0.00242076416796822,0.0236110590712455,0.0331004546096809,1.46309365326674e-31
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23460.Alanine,40404,0.0239647985941977,0.00232385468208917,0.019410043417303,0.0285195537710925,7.40400514257021e-25
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23461.Glutamine,40364,-0.010511386558959,0.00234973340562687,-0.0151168640339877,-0.00590590908393037,7.75051509051968e-06
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23462.Glycine,40390,-0.00378168770049894,0.00224933764780058,-0.00819038949018807,0.000627014089190192,0.0927349268194623
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23463.Histidine,40390,-0.00967763655451376,0.0022918097565856,-0.0141695836774215,-0.00518568943160598,2.42726709514053e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),40400,0.00103272276152434,0.00233977505742133,-0.00355323635102147,0.00561868187407016,0.6589461154804
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23465.Isoleucine,40407,-0.00167555697136616,0.00229707937329661,-0.00617783254302751,0.00282671860029519,0.465749815666773
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23466.Leucine,40408,-8.90251362135945e-05,0.00234144903838111,-0.00467826525144058,0.00450021497901339,0.969671106951764
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23467.Valine,40400,0.00286499925730034,0.00236003190992042,-0.00176066328614368,0.00749066180074435,0.224778561571881
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23468.Phenylalanine,40407,0.00996343758011389,0.00228811605412276,0.00547873011403329,0.0144481450461945,1.3424589011738e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23469.Tyrosine,40391,0.013166288736369,0.00230507912254197,0.00864833365618674,0.0176842438165513,1.13741671090537e-08
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23470.Glucose,40379,0.00871893843801196,0.00243357180452341,0.00394913770114608,0.0134887391748779,0.000340978386854271
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23471.Lactate,40378,0.0280206729654554,0.00227283978664028,0.0235659069836404,0.0324754389472703,9.16690572219835e-35
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23472.Pyruvate,40366,0.0120517364114007,0.00235980850608067,0.0074265117394826,0.0166769610833188,3.30949411736457e-07
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23473.Citrate,40409,0.0126951947335555,0.00234181935849677,0.00810522879090181,0.0172851606762092,6.00999365073128e-08
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23474.3-Hydroxybutyrate,40212,0.00252248722936091,0.00220325611875312,-0.0017958947633952,0.00684086922211702,0.252271862823848
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23475.Acetate,40397,-0.0215913562162951,0.00237144648299153,-0.0262393913229585,-0.0169433211096317,9.65409908549567e-20
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23476.Acetoacetate,40410,-0.00976014327120563,0.00228671381078526,-0.0142421023403447,-0.00527818420206652,1.9819728335337e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23477.Acetone,40410,-0.0199154367260283,0.00228741379413791,-0.0243987677625386,-0.015432105689518,3.43543676488559e-18
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23478.Creatinine,39936,0.00375394846636149,0.00270141999166107,-0.0015408347172942,0.00904873165001719,0.164664141946294
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23479.Albumin,40409,-0.0154429649448119,0.00236779179636862,-0.0200838368656944,-0.0108020930239294,7.14157851182024e-11
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23480.Glycoprotein Acetyls,40411,0.036711150556684,0.00250787338152095,0.0317957187289029,0.041626582384465,3.28323118903882e-48
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,40411,0.0418488587294156,0.00249576883411395,0.0369571518145522,0.0467405656442789,1.43707621592502e-62
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,40411,0.0398534585552248,0.00249668000205862,0.0349599657511899,0.0447469513592597,6.42171410712166e-57
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,40411,0.0416628812233473,0.00245645379742002,0.0368482317804041,0.0464775306662906,5.83866000334744e-64
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,40411,0.0422531569671111,0.00245219864788904,0.0374468476172486,0.0470594663169736,6.1659372492909e-66
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,40411,0.0420940242858966,0.00243770862698651,0.037316115377003,0.0468719331947901,3.28050332767681e-66
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,40411,0.0416446061111769,0.00246485638697464,0.0368134875927066,0.0464757246296472,1.73402456882158e-63
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,40411,0.0369742141723182,0.0025194340791423,0.0320361233771993,0.0419123049674371,1.91115727061801e-48
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,40411,0.0372488026337625,0.00245258967411991,0.0324417268724875,0.0420558783950375,9.83417807657555e-52
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,40411,0.0356744488580228,0.00245997876888676,0.0308528904710048,0.0404960072450409,2.35617183235892e-47
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,40411,0.0356158929418067,0.00243839391374618,0.0308366408708642,0.0403951450127492,5.22611741823145e-48
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,40411,0.0295008486439229,0.00237513091492934,0.0248455920506614,0.0341561052371844,2.93580404671729e-35
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,40411,0.0249045344506169,0.00233038605088441,0.0203369777908835,0.0294720911103504,1.44216215951819e-26
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,40411,0.0335801116825758,0.00242322488517314,0.0288305909076364,0.0383296324575152,2.04159613775445e-43
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,40411,0.0370678346861702,0.0024864526807287,0.032194387431942,0.0419412819403985,6.3448457885287e-50
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23495.Concentration of Large VLDL Particles,40411,0.0328608144084887,0.00243440032763005,0.0280893897663338,0.0376322390506436,2.68837559130381e-41
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23496.Total Lipids in Large VLDL,40411,0.0294228909651669,0.00243272268653922,0.02465475449955,0.0341910274307838,1.58036779662286e-33
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23497.Phospholipids in Large VLDL,40411,0.0344438472643202,0.0024150869971567,0.029710276749893,0.0391774177787473,7.22864735271416e-46
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23498.Cholesterol in Large VLDL,40411,0.0270871734340877,0.00235246247404262,0.0224763469849641,0.0316979998832112,1.47420608357037e-30
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,40411,0.0220823555246214,0.0022997326403331,0.0175748795495686,0.0265898314996743,8.96657834056147e-22
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,40411,0.0315078354358545,0.00240928803674533,0.0267856308838336,0.0362300399878753,7.00137501947034e-39
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23501.Triglycerides in Large VLDL,40411,0.0267895986660578,0.00247241780349751,0.0219436597712026,0.0316355375609129,2.91126742644779e-27
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,40411,0.0115699318375288,0.00232218709014348,0.00701844514084758,0.01612141853421,6.34763256244562e-07
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23503.Total Lipids in Medium VLDL,40411,0.0154476921632018,0.00234535767990975,0.0108507911105787,0.0200445932158249,4.64396559548509e-11
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23504.Phospholipids in Medium VLDL,40411,0.0111998772941943,0.00231625236202317,0.00666002266462891,0.0157397319237597,1.34154056164204e-06
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23505.Cholesterol in Medium VLDL,40411,-0.00415661594743103,0.00233428543647457,-0.00873181540292118,0.000418583508059128,0.0749837205738469
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,40411,-0.0126285139138181,0.00237153669993693,-0.0172767258456945,-0.00798030198194168,1.02301451374348e-07
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,40411,0.00633845193679921,0.0023110786480749,0.0018087377865724,0.010868166087026,0.00610158169716664
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23508.Triglycerides in Medium VLDL,40411,0.0265794598524749,0.00242670057967426,0.0218231267163134,0.0313357929886365,8.0819648108067e-28
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23509.Concentration of Small VLDL Particles,40411,0.0271140349883816,0.00233081225027294,0.0225456429778466,0.0316824269989166,3.74675347006476e-31
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23510.Total Lipids in Small VLDL,40411,0.025593110296312,0.00231910471587996,0.0210476650531873,0.0301385555394367,3.24863152613478e-28
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23511.Phospholipids in Small VLDL,40411,0.0148200900976518,0.00229768546483507,0.010316626586575,0.0193235536087285,1.1506076152899e-10
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23512.Cholesterol in Small VLDL,40411,0.0152561778406696,0.002271603261296,0.0108038354485295,0.0197085202328098,1.93034951106677e-11
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,40411,0.0195453331132898,0.00225629721313077,0.0151229905755535,0.0239676756510261,5.04816491108233e-18
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,40411,0.00730383547604333,0.00230368334513624,0.0027886161195763,0.0118190548325104,0.00152462815500984
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23515.Triglycerides in Small VLDL,40411,0.036957582543203,0.00239470536876104,0.0322639600204314,0.0416512050659747,2.38337053757325e-53
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,40411,0.0232356821641786,0.00234847877969111,0.018632663755984,0.0278387005723732,5.1521008986615e-23
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,40411,0.0233875070872575,0.00234737921559627,0.0187866438246888,0.0279883703498262,2.58221031341023e-23
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,40411,0.0256922503696854,0.00234170345238716,0.0211025116030065,0.0302819891363642,6.58411031746019e-28
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,40411,0.00979127455381619,0.00239473185686233,0.00509760011436602,0.0144849489932664,4.35974420978053e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,40411,0.00515940347110341,0.00241275806567088,0.000430397662388476,0.00988840927981834,0.0325007214903738
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,40411,0.0197013160047822,0.00235574998482202,0.015084046034531,0.0243185859750334,6.60990404385477e-17
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,40411,0.0449237699778728,0.00236987650078732,0.0402788120363297,0.049568727919416,2.91369892436718e-79
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23523.Concentration of IDL Particles,40411,0.00106046440798558,0.00236112629149144,-0.00356734312333764,0.0056882719393088,0.653340387350657
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23524.Total Lipids in IDL,40411,-0.00385729953785842,0.00242529082791129,-0.00861086956056454,0.000896270484847702,0.111753610500519
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23525.Phospholipids in IDL,40411,-0.00312786185201666,0.00243351090500797,-0.00789754322583228,0.00164181952179897,0.198696033314585
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23526.Cholesterol in IDL,40411,-0.0101245547099327,0.00242602962993705,-0.0148795727846093,-0.00536953663525606,3.01806601927181e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23527.Cholesteryl Esters in IDL,40411,-0.010114675621196,0.00241994409921376,-0.014857766055655,-0.00537158518673702,2.93430337813179e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23528.Free Cholesterol in IDL,40411,-0.00996585047523304,0.00244067600158367,-0.014749575438337,-0.00518212551212906,4.46298379433192e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23529.Triglycerides in IDL,40411,0.0453661235034462,0.00240474273423692,0.0406528277443418,0.0500794192625505,1.57256736699742e-78
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23530.Concentration of Large LDL Particles,40411,-0.00546250539616375,0.00234147580033326,-0.0100517979648169,-0.00087321282751055,0.0196640398480685
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23531.Total Lipids in Large LDL,40411,-0.00569675458458032,0.00236687169907325,-0.0103358231147639,-0.00105768605439676,0.0161011421880992
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23532.Phospholipids in Large LDL,40411,-0.00610281058319296,0.00235555183618359,-0.0107196921821128,-0.00148592898427313,0.00958346829265425
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23533.Cholesterol in Large LDL,40411,-0.00983586954545639,0.00237258055633858,-0.01448612743588,-0.00518561165503278,3.40613037589378e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,40411,-0.00788048806027311,0.002363453551962,-0.0125128570221186,-0.00324811909842758,0.000857058668510593
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23535.Free Cholesterol in Large LDL,40411,-0.0151430388461005,0.00239489482587389,-0.0198370327048133,-0.0104490449873876,2.63268336214724e-10
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23536.Triglycerides in Large LDL,40411,0.0458985416301829,0.00243866977396807,0.0411187488732055,0.0506783343871603,3.55546809317362e-78
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23537.Concentration of Medium LDL Particles,40411,0.00641926641452441,0.00232571536275256,0.00186086430352939,0.0109776685255194,0.00578450752199081
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23538.Total Lipids in Medium LDL,40411,0.00272307905064802,0.00233574600746622,-0.00185498312398577,0.00730114122528181,0.243701251776149
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23539.Phospholipids in Medium LDL,40411,-0.00019531527983729,0.00231879414248275,-0.00474015179910347,0.00434952123942889,0.932873508817877
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23540.Cholesterol in Medium LDL,40411,0.000319570409149105,0.00233556747752827,-0.0042581418468063,0.0048972826651045,0.891168686010171
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,40411,0.00505342038592602,0.00234358964784682,0.000459984676146261,0.00964685609570579,0.0310772038967616
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,40411,-0.0125560572600292,0.00233363232900833,-0.0171299766248855,-0.00798213789517287,7.53361967015923e-08
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23543.Triglycerides in Medium LDL,40411,0.0453046148833646,0.0024755723767579,0.0404524930249191,0.0501567367418101,4.67283126489357e-74
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23544.Concentration of Small LDL Particles,40411,0.00662920511948175,0.00231730044072041,0.00208729625566976,0.0111711139832937,0.00423195955248439
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23545.Total Lipids in Small LDL,40411,-0.00114125490638751,0.00233842289155664,-0.00572456377383853,0.00344205396106351,0.625524882210784
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23546.Phospholipids in Small LDL,40411,-0.00782664351454081,0.00232464687087378,-0.0123829513814534,-0.0032703356476282,0.000762226753274984
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23547.Cholesterol in Small LDL,40411,-0.00292745502054309,0.00233237912688279,-0.00749891810923337,0.00164400806814718,0.209447459090245
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,40411,0.003327671921972,0.00234773217464967,-0.00127388314034136,0.00792922698428535,0.156385990868286
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23549.Free Cholesterol in Small LDL,40411,-0.0185457316420472,0.00231451385097149,-0.0230821787899513,-0.014009284494143,1.19825512983206e-15
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23550.Triglycerides in Small LDL,40411,0.0429028896917016,0.00249838614703412,0.0380060528435147,0.0477997265398885,1.66103365509903e-65
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,40411,-0.0231706153882464,0.00269744913312688,-0.028457615689175,-0.0178836150873177,9.50492908894195e-18
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23552.Total Lipids in Very Large HDL,40411,-0.0282551004276616,0.0027128472328989,-0.0335722810041435,-0.0229379198511798,2.54532171608943e-25
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23553.Phospholipids in Very Large HDL,40411,-0.026773975001356,0.00271644485322605,-0.032098206913679,-0.0214497430890329,7.4849129187403e-23
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23554.Cholesterol in Very Large HDL,40411,-0.0345046422999853,0.00268894172581444,-0.0397749680825816,-0.029234316517389,1.66211622591372e-37
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,40411,-0.0379569014903056,0.00272967185728171,-0.0433070583305778,-0.0326067446500335,1.05793872038901e-43
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,40411,-0.0208109479200876,0.00251349866880852,-0.0257374053109523,-0.0158844905292229,1.33204960660456e-16
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23557.Triglycerides in Very Large HDL,40411,0.0382309536334053,0.00241864208069324,0.0334904151552465,0.042971492111564,7.41090007529261e-56
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23558.Concentration of Large HDL Particles,40411,-0.0339774891389174,0.0028502949947894,-0.0395640673287046,-0.0283909109491302,1.27019451836624e-32
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23559.Total Lipids in Large HDL,40411,-0.032387283050118,0.00283722771950549,-0.0379482493803488,-0.0268263167198873,4.59722175277199e-30
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23560.Phospholipids in Large HDL,40411,-0.0279046540600294,0.00280390020591053,-0.033400298463614,-0.0224090096564447,2.88679188370734e-23
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23561.Cholesterol in Large HDL,40411,-0.041219793699065,0.00282807058127921,-0.0467628120383723,-0.0356767753597578,8.1900851418708e-48
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,40411,-0.0436278186477784,0.00281734504835641,-0.049149814942557,-0.0381058223529999,1.06943791781495e-53
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23563.Free Cholesterol in Large HDL,40411,-0.032160772754147,0.00283247623461562,-0.0377124261739936,-0.0266091193343004,9.1844598954571e-30
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23564.Triglycerides in Large HDL,40411,0.0388558615724467,0.00239072822628555,0.034170034248927,0.0435416888959664,6.34979013220605e-59
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23565.Concentration of Medium HDL Particles,40411,-0.0119549126188289,0.00255783061651258,-0.0169682606271936,-0.00694156461046428,2.98023914046248e-06
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23566.Total Lipids in Medium HDL,40411,-0.00730311584763873,0.00253665139093894,-0.0122749525738791,-0.00233127912139841,0.00399420277963124
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23567.Phospholipids in Medium HDL,40411,-0.00167874899400301,0.00252178541362318,-0.00662144840470444,0.00326395041669842,0.505613396198106
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23568.Cholesterol in Medium HDL,40411,-0.0216456304311752,0.00256158714075421,-0.0266663412270534,-0.0166249196352969,3.15917295262712e-17
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,40411,-0.0233637329517357,0.00254772223089362,-0.0283572685242872,-0.0183701973791842,5.27459239342512e-20
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,40411,-0.0138122090485589,0.00259809907733503,-0.0189044832401356,-0.00871993485698224,1.07338728822764e-07
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23571.Triglycerides in Medium HDL,40411,0.0480638358159067,0.00229756139291012,0.0435606154858028,0.0525670561460105,6.86596255960249e-96
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23572.Concentration of Small HDL Particles,40411,-0.00144402851179741,0.00230483848741106,-0.0059615119471231,0.00307345492352827,0.530982570486517
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23573.Total Lipids in Small HDL,40411,0.0111729749915974,0.00232812631939525,0.0066098474055827,0.0157361025776121,1.60800839683407e-06
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23574.Phospholipids in Small HDL,40411,0.0141020629596845,0.0023516125947331,0.00949290227400764,0.0187112236453614,2.05631508364285e-09
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23575.Cholesterol in Small HDL,40411,-0.00592971349311289,0.00230893873666006,-0.0104552334169666,-0.00140419356925918,0.010233145537841
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,40411,-0.01037485482375,0.00228258421480827,-0.0148487198847742,-0.00590098976272576,5.52799951432974e-06
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23577.Free Cholesterol in Small HDL,40411,0.00957361667802981,0.00239309622366577,0.00488314807964491,0.0142640852764147,6.3489948884721e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23578.Triglycerides in Small HDL,40411,0.0510997806196606,0.00236825743959328,0.0464579960380577,0.0557415652012634,8.38826611334132e-102
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39531,0.0185601271834517,0.00219232255037416,0.0142631749847183,0.022857079382185,2.77201126530614e-17
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39531,-0.00627391549919222,0.00230601342674142,-0.0107937018156054,-0.00175412918277903,0.00652232751970961
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39531,-0.00178230511314958,0.00224889091673538,-0.00619013130995092,0.00262552108365177,0.428066352965775
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39531,-0.0119613450885997,0.00234614487089802,-0.0165597890355599,-0.00736290114163962,3.46871713743004e-07
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39531,-0.00178275442122873,0.00223444123351404,-0.00616225923891624,0.00259675039645879,0.424968681627999
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,40174,0.00842663452476876,0.00215805742022066,0.00419684198113626,0.0126564270684013,9.47241426645777e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,40174,-0.0304155961989296,0.00243728150503856,-0.0351926679488051,-0.025638524449054,1.42720311632072e-35
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,40174,-0.0321209283050434,0.00244179858561662,-0.036906853532852,-0.0273350030772348,2.58237619987034e-39
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,40174,-0.0184568928875104,0.00231870521389091,-0.0230015551067365,-0.0139122306682842,1.83715730363278e-15
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,40174,0.0219203513684193,0.00234473519691645,0.0173246703824631,0.0265160323543756,1.0037196850101e-20
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,40406,0.0440821146768802,0.00226989347012313,0.0396331234754389,0.0485311058783216,4.7161953089683e-83
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,40406,-0.00920893776821783,0.00226647725550892,-0.0136512331890153,-0.00476664234742036,4.86557385270804e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,40406,-0.0188206907970873,0.00237540168859468,-0.0234764781067328,-0.0141649034874417,2.46737309009008e-15
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,40406,0.0147648875984017,0.00217941536166247,0.0104932334895433,0.0190365417072602,1.29022752746694e-11
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,40406,-0.00873072266725615,0.00214010262393429,-0.0129253238101674,-0.00453612152434495,4.53361569880244e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,40411,-0.0165271637960887,0.00238980932299267,-0.0212111900691543,-0.0118431375230231,4.83282567172296e-12
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,40411,-0.0355193327654394,0.00248586570381962,-0.0403916295449258,-0.0306470359859529,4.96174153571955e-46
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,40411,-0.0379742815352783,0.00250243668198606,-0.042879057431971,-0.0330695056385856,1.18876313147154e-51
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,40411,-0.0269517198422085,0.00243784787538258,-0.0317299016779584,-0.0221735380064587,2.61120361626177e-28
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,40411,0.0319033936381299,0.00247092702320242,0.0270603766726532,0.0367464106036067,6.00397057340743e-38
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,40411,-0.0428691512226663,0.00241117977626431,-0.0475950635841444,-0.0381432388611883,4.83794861890787e-70
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,40411,-0.0240730595805203,0.00237575752236904,-0.0287295443243636,-0.0194165748366769,4.67317488247013e-24
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,40411,-0.00913460880693616,0.00231668301487781,-0.0136753075160967,-0.00459391009777565,8.0822755028658e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,40411,-0.0404171663837833,0.00242225462017386,-0.0451647854393241,-0.0356695473282425,5.57335593957222e-62
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,40411,0.0302690779702006,0.00239069046854562,0.0255833246518512,0.03495483128855,1.45369042649497e-36
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,40411,0.0260008231312624,0.00244165925900791,0.0212151709836069,0.0307864752789179,2.16522687644428e-26
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,40411,-0.0419627784210219,0.00251807091614273,-0.0468981974166617,-0.0370273594253821,7.88699098553837e-62
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,40411,-0.0432327870028666,0.00253304355630013,-0.0481975523732148,-0.0382680216325183,9.71612401876322e-65
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,40411,-0.0229426361447555,0.00247465485368758,-0.0277929596579832,-0.0180923126315279,2.0741521652611e-20
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,40411,0.0417047173267506,0.00251342902889143,0.0367783964301234,0.0466310382233778,2.56517190235238e-61
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,40411,0.00655271145224255,0.00228579227199884,0.00207255859912483,0.0110328643053603,0.00415301002201781
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,40411,-0.0379358259418471,0.00239474228819969,-0.0426295208267185,-0.0332421310569758,4.31938814061824e-56
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,40411,-0.0336471079946617,0.00239061744951914,-0.0383327181957192,-0.0289614977936042,1.00654604952573e-44
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,40411,-0.028012537457597,0.00247431805298397,-0.0328622008414456,-0.0231628740737484,1.33468525310872e-29
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,40411,0.0501483849900576,0.00246274569621632,0.0453214034254736,0.0549753665546416,5.11401716089826e-91
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,40411,-0.00180162260630964,0.00227618199179425,-0.00626293931022637,0.00265969409760708,0.428657745749223
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,40411,-0.0572875020107123,0.00245931630226418,-0.0621077619631501,-0.0524672420582745,4.70795961613239e-118
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,40411,-0.0274315887553852,0.00229593088428004,-0.0319316132885741,-0.0229315642221963,9.18438093121412e-33
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,40411,-0.0405211824185209,0.00247611347245912,-0.0453743648245407,-0.035668000012501,1.04439113926493e-59
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,40411,0.0557531920139174,0.00244751402851749,0.0509560645180232,0.0605503195098117,4.61857053359262e-113
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,40411,-0.0233834125658413,0.00224353316697379,-0.0277807375731099,-0.0189860875585727,2.35874775662575e-25
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,40411,-0.0280204971491733,0.00230789841343939,-0.0325439780395145,-0.0234970162588321,9.00864300946415e-34
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,40411,0.0178945861726171,0.00234478691139307,0.0132988038262867,0.0224903685189475,2.44833011185207e-14
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,40411,-0.0508944980253591,0.00251199269654718,-0.0558180037105915,-0.0459709923401266,3.88673979609942e-90
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,40411,0.0480552469607682,0.00237227065579808,0.0434055964754039,0.0527048974461324,4.16891895285942e-90
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,40411,-0.0255324228739739,0.00229362417919596,-0.0300279262651979,-0.0210369194827498,1.11884540657686e-28
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,40411,-0.0142431036349681,0.00233084271077823,-0.0188115553480934,-0.00967465192184278,1.01493059770274e-09
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,40411,0.0241206343490228,0.00231514165966115,0.019582956696087,0.0286583120019587,2.4578546174383e-25
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,40411,-0.0487217491928146,0.00245835866866202,-0.0535401321833922,-0.0439033662022371,2.23609341497353e-86
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,40411,0.0508183494383475,0.0024259843973919,0.0460634200194594,0.0555732788572356,3.87467388341792e-96
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,40409,-0.0147561259745564,0.00264914878362469,-0.0199484575904608,-0.00956379435865204,2.58647523639681e-08
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,40409,-0.0184974492490322,0.00264116811028456,-0.02367413874519,-0.0133207597528745,2.59589901439529e-12
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,40409,-0.0457983807917772,0.00262542351500373,-0.0509442108811845,-0.0406525507023699,1.61170619523082e-67
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,40409,0.0321203661228199,0.00280150895381665,0.0266294085733393,0.0376113236723005,2.58785734499573e-30
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,40409,0.0547235394992289,0.00260374113785287,0.0496202068690372,0.0598268721294205,9.29832354658313e-97
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,40411,0.0469030689456978,0.0027271835911793,0.0415577891069864,0.0522483487844093,1.06753918039703e-65
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,40411,-0.06509448496638,0.00268358018916312,-0.0703543021371397,-0.0598346677956203,1.14198511627646e-127
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,40411,-0.0685649586957663,0.0027072466257765,-0.0738711620822883,-0.0632587553092444,8.86979399918724e-139
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,40411,-0.0198521928050732,0.00264785302075899,-0.0250419847257609,-0.0146624008843856,6.84753933357521e-14
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,40411,0.0650887500317622,0.00260217233581358,0.0599884922535675,0.0701890078099568,1.76278235956325e-135
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,40411,0.0472330207280257,0.00256238776621804,0.0422107407062383,0.052255300749813,4.27724995621268e-75
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,40411,-0.056584009093689,0.00248361874735121,-0.0614519018384974,-0.0517161163488807,4.28703502613564e-113
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,40411,-0.0565662560145163,0.00246858115001253,-0.0614046750685409,-0.0517278369604917,2.31903763931313e-114
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,40411,-0.0306378202567532,0.00270460635927935,-0.0359388487209407,-0.0253367917925657,1.23722049057061e-29
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,40411,0.0577434531218811,0.00241444133471576,0.0530111481058382,0.062475758137924,3.18145931880937e-124
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,40411,0.0211456023257222,0.00240412534871757,0.0164335166422357,0.0258576880092086,1.56670608727232e-18
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,40411,-0.0509304190045685,0.00237617129783483,-0.0555877147483248,-0.0462731232608122,1.68140755544637e-100
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,40411,-0.0487396838790374,0.00238806702635157,-0.0534202952506865,-0.0440590725073884,2.01012820749618e-91
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,40411,-0.00589834302074294,0.00245938881614145,-0.0107187451003802,-0.00107794094110571,0.0164829458162255
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,40411,0.0552698232034062,0.00241521865030341,0.0505359946488115,0.0600036517580009,4.56580854780602e-114
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,51916,-0.00303322166549565,0.00200414468164985,-0.00696134524152936,0.000894901910538061,0.130170706662367
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,51916,-0.00210494666037833,0.00196471194330548,-0.00595578206925706,0.0017458887485004,0.284009485551935
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,50033,-0.000408552122080611,0.00188288002375251,-0.00409899696863552,0.0032818927244743,0.828223668993392
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,50033,-0.00113155787142625,0.00204973112972814,-0.00514903088569341,0.00288591514284092,0.580917649302576
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,50033,-0.00204124477262369,0.00201229431594385,-0.00598534163187365,0.00190285208662626,0.310407818946786
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,50033,-0.00234597275054447,0.00184405622019577,-0.00596032294212819,0.00126837744103925,0.203320484000008
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24009.Traffic intensity on the nearest road,51916,0.032198703221943,0.0866786753971627,-0.137691500556496,0.202088907000382,0.710288852975555
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24010.Inverse distance to the nearest road,51916,0.00186550354551529,0.00175183548173224,-0.00156809399867989,0.00529910108971048,0.28693727920503
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24011.Traffic intensity on the nearest major road,51916,-0.00154377095526547,0.00175487772769298,-0.00498333130154371,0.00189578939101278,0.379027996963454
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24012.Inverse distance to the nearest major road,51916,-0.000889728794363353,0.00178606997559617,-0.00439042594653184,0.00261096835780514,0.618383084976455
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24013.Total traffic load on major roads,51916,0.0173672720197946,0.0603830037558719,-0.100983415341714,0.135717959381304,0.773640913552195
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24015.Sum of road length of major roads within 100m,51916,0.0116607066983669,0.0584391540240917,-0.102880035188853,0.126201448585587,0.841845074452207
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,51916,-0.00444572683204878,0.00199057733944867,-0.00834725841736817,-0.000544195246729391,0.0255315461327368
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,51916,-0.00473123796484715,0.00198620739960613,-0.00862420446807517,-0.000838271461619124,0.0172234996975782
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,51916,-0.00448551007160292,0.00196683756885665,-0.00834051170656195,-0.000630508436643889,0.0225815501354798
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,51851,-0.001304759476016,0.00193832433322057,-0.00510387516912832,0.00249435621709632,0.500865272890023
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24020.Average daytime sound level of noise pollution,51916,0.000178151482053151,0.001765165245196,-0.00328157239853102,0.00363787536263732,0.919609753782298
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24021.Average evening sound level of noise pollution,51916,0.000220698776688328,0.00176493268046886,-0.00323856927703063,0.00367996683040729,0.900487597928732
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24022.Average night-time sound level of noise pollution,51916,0.000179277280926949,0.00176513070072765,-0.00328037889249924,0.00363893345435313,0.919101902088788
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24023.Average 16-hour sound level of noise pollution,51916,0.000201855787363338,0.00176503010783669,-0.00325760322399657,0.00366131479872325,0.908950138600413
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24024.Average 24-hour sound level of noise pollution,51916,0.000201702306091556,0.00176503131385976,-0.00325775906907357,0.00366116368125669,0.909019129395604
PLA2G15,Phospholipase A2 group XV,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",48942,0.00397677130127523,0.0020500023591861,-4.1233322729527e-05,0.00799477592527999,0.0524049866128848
PLA2G15,Phospholipase A2 group XV,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",48942,-0.00140361138495834,0.001869495958721,-0.0050678234640515,0.00226060069413482,0.452782233142323
PLA2G15,Phospholipase A2 group XV,Working and living environment,"X24502.Water percentage, buffer 1000m",48942,-0.000831171741301834,0.00183522252430124,-0.00442820788893227,0.0027658644063286,0.650624974982992
PLA2G15,Phospholipase A2 group XV,Working and living environment,"X24503.Greenspace percentage, buffer 300m",48942,0.00277212886464413,0.00193144992171448,-0.00101351298191625,0.00655777071120451,0.15122637497428
PLA2G15,Phospholipase A2 group XV,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",48942,-0.00132415756825734,0.00188418964347993,-0.005017169269478,0.00236885413296332,0.482203919246112
PLA2G15,Phospholipase A2 group XV,Working and living environment,"X24505.Water percentage, buffer 300m",48942,-0.00230087635985427,0.00184362015977319,-0.00591437187300972,0.00131261915330118,0.212035361563664
PLA2G15,Phospholipase A2 group XV,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",52075,0.00290682929180866,0.0019544719776042,-0.000923935784295581,0.00673759436791289,0.136954691857562
PLA2G15,Phospholipase A2 group XV,Working and living environment,"X24507.Natural environment percentage, buffer 300m",52075,0.00226460922226482,0.00184324195621533,-0.00134814501191724,0.00587736345644687,0.219231843937626
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24508.Distance (Euclidean) to coast,52075,-0.0023004853435448,0.00176186183710424,-0.0057537345442691,0.00115276385717951,0.191661157832981
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,35684,0.105873721463013,0.0638233834211715,-0.0192201100424835,0.230967552968509,0.097172991685974
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2704.Years since last cervical smear test,45581,0.0596584115964223,0.0470171985482137,-0.0324952975580765,0.151812120750921,0.204503696953208
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2714.Age when periods started (menarche),51413,0.0736162946480407,0.0395999414530418,-0.00399959059992121,0.151232179896003,0.0630380137273764
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2734.Number of live births,52251,0.0908040490305315,0.0379464914874382,0.0164289257151526,0.16517917234591,0.0167201238636756
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2744.Birth weight of first child,46493,-0.180822300963151,0.0424154782822721,-0.263956638396404,-0.0976879635298975,2.02430029416702e-05
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2754.Age at first live birth,43216,-0.0112834287233074,0.00222243951402377,-0.015639410170794,-0.00692744727582081,3.87014201765978e-07
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2764.Age at last live birth,43165,-0.00533574959435584,0.00214774519497985,-0.00954533017651635,-0.00112616901219533,0.012987515334847
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2794.Age started oral contraceptive pill,45776,0.00232435684403084,0.00241234245629183,-0.00240383437030114,0.00705254805836282,0.335294098489741
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2804.Age when last used oral contraceptive pill,43790,-0.00812460793247281,0.00208891473816432,-0.0122188808192749,-0.00403033504567074,0.000100831910881577
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X2867.Age started smoking in former smokers,30116,-0.000145456543220751,0.00406028274054161,-0.00810361071468231,0.00781269762824081,0.971423767189425
PLA2G15,Phospholipase A2 group XV,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",35598,0.241228210262098,0.0720383206268247,0.100033101833521,0.382423318690674,0.000814873464688656
PLA2G15,Phospholipase A2 group XV,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,35591,0.295223425766657,0.0782203307443754,0.141911577507681,0.448535274025633,0.000161319802721615
PLA2G15,Phospholipase A2 group XV,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,35630,0.318763435838057,0.085049042098781,0.152067313324446,0.485459558351667,0.000179151271699085
PLA2G15,Phospholipase A2 group XV,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",35583,0.29462922084936,0.0817185648998367,0.13446083364568,0.45479760805304,0.000313018925870748
PLA2G15,Phospholipase A2 group XV,Mental health,X28739.Difficulty with standing for long periods,35642,0.332392366185756,0.0724281691495725,0.190433154652594,0.474351577718918,4.49641530108457e-06
PLA2G15,Phospholipase A2 group XV,Mental health,X28740.Difficulty with taking care of household responsibilities,35671,0.386846355075286,0.0783764821478371,0.233228450065525,0.540464260085047,8.09934190295695e-07
PLA2G15,Phospholipase A2 group XV,Mental health,X28741.Difficulty learning a new task,35560,0.289628233421732,0.0871657237663565,0.118783414839674,0.460473052003791,0.000894289737302778
PLA2G15,Phospholipase A2 group XV,Mental health,X28742.Difficulty with joining in community activities,35281,0.406316358117747,0.092359122730992,0.225292477565003,0.587340238670491,1.0963427901504e-05
PLA2G15,Phospholipase A2 group XV,Mental health,X28743.Difficulty with being emotionally affected by health problems,35594,0.360493911215549,0.0768798432810678,0.209809418384656,0.511178404046442,2.77727345656822e-06
PLA2G15,Phospholipase A2 group XV,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,35664,0.412184466310687,0.11221217968663,0.192248594124892,0.632120338496483,0.000240590925385814
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,30085,0.0902381780071872,0.088087205421592,-0.0824127446191331,0.262889100633507,0.305681563749418
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X2897.Age stopped smoking,30126,0.017945605641299,0.00418311839486557,0.00974669358736244,0.0261445176952355,1.81636179663077e-05
PLA2G15,Phospholipase A2 group XV,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,34526,-0.00440866922082623,0.00564081467653158,-0.0154646659868281,0.00664732754517566,0.434488015404594
PLA2G15,Phospholipase A2 group XV,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,34526,0.00840228349733787,0.00601108176649824,-0.00337943676499868,0.0201840037596744,0.162204241122021
PLA2G15,Phospholipase A2 group XV,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,34526,0.000190494913424297,0.0200163073052638,-0.0390414674048927,0.0394224572317413,0.992406846997286
PLA2G15,Phospholipase A2 group XV,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,34526,-0.0198830724556747,0.021178814958628,-0.0613935497745857,0.0216274048632362,0.34784622466475
PLA2G15,Phospholipase A2 group XV,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,34526,0.0274745839235185,0.0222468099235197,-0.0161291635265801,0.0710783313736172,0.216863093176132
PLA2G15,Phospholipase A2 group XV,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,34526,-0.00508655420339885,0.0183320954003065,-0.0410174611879995,0.0308443527812018,0.781427122455148
PLA2G15,Phospholipase A2 group XV,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,34526,0.00390552178272403,0.00850051651694049,-0.0127554905904793,0.0205665341559274,0.645924386928897
PLA2G15,Phospholipase A2 group XV,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,34526,0.0120242284773097,0.0149906165513497,-0.0173573799633357,0.0414058369179551,0.422504198906918
PLA2G15,Phospholipase A2 group XV,Mental health,X29002.Recent lack of interest or pleasure in doing things,34456,0.195153173419435,0.0872193148126583,0.0242033163866251,0.366103030452245,0.0252756447598975
PLA2G15,Phospholipase A2 group XV,Mental health,X29003.Recent feelings of depression,34440,0.256643902338432,0.0831821331553011,0.0936069213540419,0.419680883322822,0.00203885881483185
PLA2G15,Phospholipase A2 group XV,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",34459,0.0197155510262542,0.0684901952240089,-0.114525231612803,0.153956333665312,0.773460277931818
PLA2G15,Phospholipase A2 group XV,Mental health,X29005.Recent feelings of tiredness or low energy,34467,0.243469767968254,0.0701178854291807,0.106038712527059,0.380900823409448,0.000518213781273736
PLA2G15,Phospholipase A2 group XV,Mental health,X29006.Recent poor appetite or overeating,34474,0.184155590032982,0.0894404913346461,0.00885222701707572,0.359458953048889,0.0395225764662047
PLA2G15,Phospholipase A2 group XV,Mental health,X29007.Recent feelings of inadequacy,34426,0.150277622663841,0.0899688329843387,-0.0260612899854624,0.326616535313145,0.094885513700401
PLA2G15,Phospholipase A2 group XV,Mental health,X29008.Recent trouble concentrating on things,34474,0.152761173358521,0.0904978187388279,-0.0246145513695816,0.330136898086624,0.0914405347816476
PLA2G15,Phospholipase A2 group XV,Mental health,X29009.Recent changes in speed or amount of moving or speaking,34460,0.18599000217839,0.160528596780101,-0.128646047510607,0.500626051867388,0.246642931494123
PLA2G15,Phospholipase A2 group XV,Mental health,X29010.Recent thoughts of suicide or self-harm,34397,0.44600219296028,0.18094008317129,0.0913596299445515,0.800644755976009,0.013721295358499
PLA2G15,Phospholipase A2 group XV,Mental health,X29038#0.Substances taken for depression_None of options listed,33126,-0.0201181168622113,0.0112043115256708,-0.042078567452526,0.00184233372810347,0.0725978491186367
PLA2G15,Phospholipase A2 group XV,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),33126,-0.0185566613316491,0.0227921616661155,-0.0632292981972356,0.0261159755339373,0.415570746975203
PLA2G15,Phospholipase A2 group XV,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),33126,-0.00508163139876206,0.0105556218300265,-0.025770650185614,0.0156073873880899,0.630233943332704
PLA2G15,Phospholipase A2 group XV,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),33126,0.00639212141651981,0.0304519899478359,-0.0532937788812385,0.0660780217142782,0.833744277189818
PLA2G15,Phospholipase A2 group XV,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),33126,0.00105288073364079,0.0191521187473884,-0.0364852720112405,0.0385910334785221,0.95615993783704
PLA2G15,Phospholipase A2 group XV,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),33126,0.0276173716445412,0.0202211745511394,-0.012016130475692,0.0672508737647744,0.172048159715747
PLA2G15,Phospholipase A2 group XV,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),33126,-0.00604365287089345,0.0231984046280919,-0.0515125259419535,0.0394252202001666,0.794468724605317
PLA2G15,Phospholipase A2 group XV,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),33126,0.0302209337410688,0.0268139606950011,-0.0223344292211334,0.082776296703271,0.259748429725218
PLA2G15,Phospholipase A2 group XV,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),33126,0.0150253432720295,0.0204970950555464,-0.0251489630368414,0.0551996495809005,0.463549298602031
PLA2G15,Phospholipase A2 group XV,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,33126,-0.00743174632047926,0.0113381729076303,-0.0296545652194346,0.0147910725784761,0.512187453663743
PLA2G15,Phospholipase A2 group XV,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,33126,-0.0131860112233368,0.0171440249993879,-0.0467883002221371,0.0204162777754635,0.441836138041261
PLA2G15,Phospholipase A2 group XV,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,33126,-0.0468797624862356,0.0265033332074487,-0.0988262955728351,0.00506677060036384,0.0769581946318465
PLA2G15,Phospholipase A2 group XV,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,33126,-0.0367017895895059,0.0353311348239983,-0.105950813844543,0.0325472346655308,0.298929261321471
PLA2G15,Phospholipase A2 group XV,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,33126,0.00240097342148457,0.0227640650337369,-0.0422165940446398,0.0470185408876089,0.916003657516173
PLA2G15,Phospholipase A2 group XV,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,33126,-0.0248210817662514,0.0386568830281711,-0.100588572501467,0.050946408968964,0.520833669409367
PLA2G15,Phospholipase A2 group XV,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,33126,-0.0478469851195161,0.0370146755145468,-0.120395749128028,0.0247017788889957,0.196166898246228
PLA2G15,Phospholipase A2 group XV,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,33126,-0.00804511216589323,0.0196193016834635,-0.0464989434654817,0.0304087191336952,0.68177126439719
PLA2G15,Phospholipase A2 group XV,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,33126,-0.000226165825997611,0.0192496810911647,-0.0379555407646805,0.0375032091126853,0.990626085335432
PLA2G15,Phospholipase A2 group XV,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,33126,-0.0183818928569126,0.0265108278104873,-0.0703431153654676,0.0335793296516425,0.488094052114239
PLA2G15,Phospholipase A2 group XV,Mental health,X29058.Recent feelings or nervousness or anxiety,34310,0.184457427823303,0.077264193957054,0.0330196076674768,0.335895247979129,0.0169886080241303
PLA2G15,Phospholipase A2 group XV,Mental health,X29059.Recent inability to stop or control worrying,34324,0.242575681280755,0.0795540231269203,0.0866497959519914,0.398501566609519,0.00230063881077423
PLA2G15,Phospholipase A2 group XV,Mental health,X29060.Recent worrying too much about different things,34314,0.210839170013997,0.0746508748289735,0.0645234553492088,0.357154884678785,0.00474737370128544
PLA2G15,Phospholipase A2 group XV,Mental health,X29061.Recent trouble relaxing,34320,0.229387946545819,0.0786930811309867,0.0751495075290854,0.383626385562553,0.00356523103524933
PLA2G15,Phospholipase A2 group XV,Mental health,X29062.Recent restlessness,34332,0.205579177611361,0.113996900674679,-0.01785474771101,0.429013102933731,0.0713597767369501
PLA2G15,Phospholipase A2 group XV,Mental health,X29063.Recent easy annoyance or irritability,34299,0.0610198806038443,0.0823904228886086,-0.100465348257829,0.222505109465517,0.45894238273625
PLA2G15,Phospholipase A2 group XV,Mental health,X29064.Recent feelings of foreboding,34284,0.206261713177301,0.0893495451106926,0.0311366047603433,0.381386821594258,0.0209930544636316
PLA2G15,Phospholipase A2 group XV,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,33126,0.00655245462933425,0.0110796338143619,-0.0151636276468151,0.0282685369054836,0.554270318876843
PLA2G15,Phospholipase A2 group XV,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,33126,-0.0253751858326264,0.0195782261132249,-0.0637485090145472,0.0129981373492944,0.194978211690796
PLA2G15,Phospholipase A2 group XV,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',33126,0.00672116775649079,0.0242163797676066,-0.0407429365880181,0.0541852721009997,0.781367237205549
PLA2G15,Phospholipase A2 group XV,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,33126,0.0255102898115768,0.0263886329088764,-0.026211430689821,0.0772320103129745,0.333713430162113
PLA2G15,Phospholipase A2 group XV,Mental health,X29065#2.Symptoms of panic attack_Sweating,33126,0.0214136008681528,0.0182205863926763,-0.0142987484614927,0.0571259501977982,0.239930115845736
PLA2G15,Phospholipase A2 group XV,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,33126,0.0122591145791599,0.0180292707759693,-0.0230782561417401,0.0475964853000598,0.496550336332635
PLA2G15,Phospholipase A2 group XV,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,33126,0.00994359916842854,0.0184822154503312,-0.0262815431142206,0.0461687414510777,0.59058460461326
PLA2G15,Phospholipase A2 group XV,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,33126,0.00315544622181394,0.0165694621734144,-0.0293206996380783,0.0356315920817062,0.848970805717208
PLA2G15,Phospholipase A2 group XV,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,33126,0.0115037436053049,0.0222064381963945,-0.0320208752596283,0.0550283624702381,0.604446075791889
PLA2G15,Phospholipase A2 group XV,Mental health,X29076.Felt loved as a child,34288,-0.117581759393425,0.0725272865875425,-0.259735241105008,0.0245717223181584,0.105005271405683
PLA2G15,Phospholipase A2 group XV,Mental health,X29077.Physically abused by family as a child,34303,-0.0437022157400477,0.101475019457368,-0.242593253876489,0.155188822396393,0.666717981697765
PLA2G15,Phospholipase A2 group XV,Mental health,X29078.Felt hated by family member as a child,34281,0.226390109658263,0.0947717436731512,0.0406374920588867,0.41214272725764,0.0169225638154846
PLA2G15,Phospholipase A2 group XV,Mental health,X29079.Sexually molested as a child,34170,0.0397136416816242,0.1203085552405,-0.196091126589755,0.275518409953003,0.74133285474497
PLA2G15,Phospholipase A2 group XV,Mental health,X29080.Someone to take to doctor when needed as a child,34255,-0.278807898515778,0.102412787995909,-0.47953696298776,-0.0780788340437965,0.0064925563137597
PLA2G15,Phospholipase A2 group XV,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,34283,-0.0165424883011214,0.124848558602286,-0.261245663161602,0.228160686559359,0.894591191090079
PLA2G15,Phospholipase A2 group XV,Mental health,X29082.Belittlement by partner or ex-partner as an adult,34203,0.0681529888412414,0.0947525667815213,-0.11756204205054,0.253868019733023,0.471989798947508
PLA2G15,Phospholipase A2 group XV,Mental health,X29083.Physical violence by partner or ex-partner as an adult,34285,0.107295525531341,0.105953443740198,-0.100373224199446,0.314964275262129,0.31124430246846
PLA2G15,Phospholipase A2 group XV,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,34243,0.106401042415255,0.13061573958857,-0.149605807178342,0.362407892008852,0.415314720704602
PLA2G15,Phospholipase A2 group XV,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,34249,0.0255283235005073,0.130657424069063,-0.230560227674857,0.281616874675871,0.845096673071266
PLA2G15,Phospholipase A2 group XV,Mental health,X29086.Experienced a violent or sexual assault,34279,0.0406444042820369,0.122848211140632,-0.200138089553602,0.281426898117675,0.740764392988506
PLA2G15,Phospholipase A2 group XV,Mental health,X29087.Experienced a life-threatening injury or illness,34289,0.267815007305824,0.0881816235365714,0.0949790251741446,0.440650989437504,0.00239504688062187
PLA2G15,Phospholipase A2 group XV,Mental health,X29088.Experienced a marital separation or divorce,34298,0.0448199630099341,0.0778076233092289,-0.107682978676155,0.197322904696023,0.564604268734737
PLA2G15,Phospholipase A2 group XV,Mental health,X29089.Experienced the death of a spouse or partner,34305,0.0122528025208184,0.0993555754782323,-0.182484125416517,0.206989730458154,0.901854044259869
PLA2G15,Phospholipase A2 group XV,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,34289,0.0694623882723387,0.0987884995407376,-0.124163070827507,0.263087847372184,0.48198361758347
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29091.Frequency of drinking alcohol,34305,-0.135602829340979,0.0650874409471953,-0.263174213597482,-0.0080314450844762,0.0372409826708849
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,33039,-0.104363590220451,0.0806878313804898,-0.262511739726211,0.0537845592853093,0.195899204141581
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,33056,-0.0799161536825189,0.0818889437987635,-0.240418483528095,0.0805861761630577,0.329137029769343
PLA2G15,Phospholipase A2 group XV,Mental health,X29104.Ever used cannabis,34298,-0.13650309140627,0.0997558419345273,-0.332024541597944,0.0590183587854033,0.171226926072483
PLA2G15,Phospholipase A2 group XV,Mental health,X29108.Ever thought that life not worth living,34243,0.0180023481001196,0.0791416853236381,-0.137115355134211,0.17312005133445,0.820063152976872
PLA2G15,Phospholipase A2 group XV,Mental health,X29109.Ever contemplated self-harm,34282,0.0063388487914294,0.104768115725055,-0.199006658029679,0.211684355612538,0.951755774063905
PLA2G15,Phospholipase A2 group XV,Mental health,X29111.Ever self-harmed,34295,0.165237526086546,0.16207811379955,-0.152435576960572,0.482910629133664,0.307993964919315
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,34287,-0.205231250680409,0.108916451977473,-0.418707496556256,0.00824499519543781,0.0595539018033969
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,33845,-0.0583461299864012,0.0241637827528156,-0.10570714418192,-0.0109851157908826,0.0157710178129511
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,33845,-0.0623705862253134,0.0184906127072354,-0.0986121871314948,-0.026128985319132,0.00074628759484596
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,33845,-0.0528145788130882,0.0186680504723065,-0.0894039577388089,-0.0162251998873675,0.00467718139907092
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,33845,-0.0678580161782927,0.024205688771182,-0.115301166169809,-0.0204148661867761,0.00506719868263465
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,34281,-0.0112330778736669,0.073003011222904,-0.154318979870559,0.131852824123225,0.877714269094374
PLA2G15,Phospholipase A2 group XV,Health and medical history,X29153.Pain or discomfort today,34293,0.17700544300683,0.0709551305920635,0.0379333870463854,0.316077498967274,0.0126258046894846
PLA2G15,Phospholipase A2 group XV,Mental health,X29154.Anxiety or depression today,34293,0.168475605101291,0.0838561221756102,0.00411760563709487,0.332833604565487,0.0445534536298719
PLA2G15,Phospholipase A2 group XV,Mental health,X29166.Frequency of confiding in someone close,34044,-0.109134003372712,0.0689199121134745,-0.244217031115122,0.0259490243696978,0.113342766602699
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,34256,0.0148683912189247,0.00602958530332823,0.00305040402440142,0.0266863784134481,0.0136837065343204
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,34256,-0.0147716814371504,0.00591178132939576,-0.0263587728427661,-0.00318459003153472,0.0124817300687178
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,34256,-0.00284258225648674,0.00862675462148624,-0.0197510213145998,0.0140658568016263,0.741778998085519
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,34256,-0.0133013822761368,0.00756107667536852,-0.0281210925598591,0.00151832800758553,0.0785761662587273
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,34256,-0.0314764731587601,0.0111615932794091,-0.053353195986402,-0.00959975033111822,0.00481095688009146
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,34256,-0.00998781414246065,0.00591588882646206,-0.0215829562423263,0.00160732795740499,0.0913848415452611
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,34258,0.000355696883660503,0.00657018251700963,-0.0125218608496784,0.0132332546169994,0.95682627832405
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,34258,-0.00751869794826233,0.00920085989772758,-0.0255523833478084,0.0105149874512837,0.413849195441888
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,34258,0.0448430248590319,0.0192212667036264,0.00716934211992408,0.0825167075981397,0.0196687815353502
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,34258,0.00869764470841424,0.0126773283295432,-0.0161499188174904,0.0335452082343189,0.492679713926562
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,34258,-0.0275731518457466,0.0178602518298231,-0.0625792454321998,0.00743294174070669,0.122662343139774
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,34258,-0.00223231368593382,0.0093481630364599,-0.0205547132373952,0.0160900858655276,0.811267953790785
PLA2G15,Phospholipase A2 group XV,Mental health,X29171.Frequency of feeling 'in tune' with people,34146,-0.165067557370654,0.0851862494058202,-0.332032606206061,0.00189749146475396,0.052685744098867
PLA2G15,Phospholipase A2 group XV,Mental health,X29172.Freuency of feeling that lacks companionship,34232,0.218639571395907,0.0759509074757114,0.0697757927435123,0.367503350048301,0.00400188881470613
PLA2G15,Phospholipase A2 group XV,Mental health,X29173.Frequency of feeling left out,34173,0.0481497182066357,0.0788778136466944,-0.106450796540885,0.202750232954157,0.541588464445017
PLA2G15,Phospholipase A2 group XV,Mental health,X29174.Frequency of feeling isolated from others,34204,0.199695039381789,0.082345513248003,0.0382978334157028,0.361092245347875,0.0153227562109034
PLA2G15,Phospholipase A2 group XV,Mental health,X29175.Tendency to bounce back quickly after hard times,34278,-0.0290987514806554,0.0685811927110132,-0.163517889194241,0.10532038623293,0.671358974138593
PLA2G15,Phospholipase A2 group XV,Mental health,X29176.Ability to make it through stressful events,34278,0.0796118499278575,0.0668947845406918,-0.0515019277718983,0.210725627627613,0.234033696724826
PLA2G15,Phospholipase A2 group XV,Mental health,X29177.Quick recovery from stressful events,34278,0.00562544761568313,0.0675386446733474,-0.126750295944078,0.138001191175444,0.933620836853428
PLA2G15,Phospholipase A2 group XV,Mental health,X29178.Hard to snap back when something bad happens,34278,0.0719241991788028,0.0672752124259759,-0.05993521717611,0.203783615533716,0.285049076732168
PLA2G15,Phospholipase A2 group XV,Mental health,X29179.Comes through difficult times with little trouble,34278,0.0561642300742189,0.0683041099431812,-0.0777118254144164,0.190040285562854,0.410944791526483
PLA2G15,Phospholipase A2 group XV,Mental health,X29180.Tendency to take a long time to get over setbacks,34278,0.0521676384365722,0.0675326369406418,-0.0801963299670857,0.18453160684023,0.439848535963293
PLA2G15,Phospholipase A2 group XV,Mental health,X29181.General happiness,34219,0.0549754108029999,0.0705701505104717,-0.0833420841975246,0.193292905803524,0.435988049030326
PLA2G15,Phospholipase A2 group XV,Mental health,X29182.Belief that own life is meaningful,34125,-0.200385326482368,0.0694400725253317,-0.336487868632018,-0.0642827843327181,0.00391370384197719
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,29657,0.0303487081251314,0.087859211091128,-0.14185534561348,0.202552761863742,0.729789358758442
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2946.Father's age,30733,-0.00604247773841009,0.00540139485164402,-0.0166292116476324,0.00454425617081219,0.263315879100803
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2966.Age high blood pressure diagnosed,30379,-0.00168186298933228,0.004537187727525,-0.0105747509352813,0.00721102495661672,0.710886140418019
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30000.White blood cell (leukocyte) count,51342,0.0110009600863209,0.00185190546766782,0.00737122536969194,0.0146306948029498,2.87915849678676e-09
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,51342,0.00275237244984168,0.00216940132685877,-0.0014996541508015,0.00700439905048486,0.204550350604016
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30020.Haemoglobin concentration,51342,0.00117308783120121,0.00235758933918361,-0.00344778727359866,0.00579396293600108,0.6187846122376
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30030.Haematocrit percentage,51342,0.00036722000857532,0.00228670007411701,-0.00411471213669402,0.00484915215384466,0.872417936134338
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30040.Mean corpuscular volume,51342,-0.00153997428161562,0.00182095552958242,-0.00510904711959716,0.00202909855636592,0.397730041400968
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30050.Mean corpuscular haemoglobin,51341,-0.000563238459278257,0.00182372916655684,-0.00413774762572966,0.00301127070717315,0.757446490458617
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,51341,-0.00149935013997564,0.00178522174124344,-0.00499838475281278,0.00199968447286151,0.400990017369641
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,51342,0.0153468272902417,0.00172306951772701,0.0119696110354967,0.0187240435449866,5.58276168827081e-19
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30080.Platelet count,51342,0.0157074134396972,0.00182504651168245,0.0121303222767996,0.0192845046025948,7.9311242831774e-18
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30090.Platelet crit,51342,0.0136472854142493,0.00187051181204786,0.00998108226263552,0.0173134885658631,3.0461281799373e-13
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,51342,-0.00855489240913227,0.00176904417621018,-0.0120222189945042,-0.00508756582376031,1.33287527597086e-06
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30110.Platelet distribution width,51342,0.00588106716452377,0.00176715435862178,0.00241744462162508,0.00934468970742246,0.000875932363997491
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30120.Lymphocyte count,51303,-0.00428609746118515,0.00184188441756147,-0.00789619091960564,-0.000676004002764673,0.0199717259492007
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30130.Monocyte count,51303,0.0217508764659711,0.0018664668993199,0.0180926013433041,0.0254091515886381,2.61980246787073e-31
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30140.Neutrophill count,51303,0.0108299531226664,0.00183853701623271,0.00722642057085024,0.0144334856744825,3.89548854455996e-09
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30150.Eosinophill count,51303,0.00989623653754577,0.00181236980018881,0.0063439917291757,0.0134484813459158,4.79311855875263e-08
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30160.Basophill count,51303,0.134605841635256,0.0430132449579128,0.0502998815177471,0.218911801752765,0.00175348559150066
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30170.Nucleated red blood cell count,51303,0.446590464704208,0.18809748144195,0.0779194010779873,0.81526152833043,0.017591623571249
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30180.Lymphocyte percentage,51303,-0.0144780826802353,0.00181569792156544,-0.0180368506065036,-0.010919314753967,1.5989836253084e-15
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30190.Monocyte percentage,51303,0.0160904507159038,0.00184142843531561,0.0124812509826852,0.0196996504491224,2.50777376812773e-18
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30200.Neutrophill percentage,51303,0.00626207404076488,0.00180244678321302,0.00272927834566735,0.0097948697358624,0.0005131724941757
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30210.Eosinophill percentage,51303,0.00635793796048888,0.00179161943601871,0.00284636386589221,0.00986951205508554,0.000387783659896761
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30220.Basophill percentage,51303,0.000425241302848972,0.00171595344313387,-0.00293802744569342,0.00378851005139136,0.804278406229195
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30230.Nucleated red blood cell percentage,51303,0.442529774550645,0.188069548488943,0.073913459512317,0.811146089588973,0.0186292402266907
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30240.Reticulocyte percentage,50855,0.0312014728897581,0.00187286343264098,0.0275306605617818,0.0348722852177344,5.33079821514294e-62
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30250.Reticulocyte count,50855,0.0320951681676471,0.00193540080717718,0.0283017825855798,0.0358885537497144,1.88647246271955e-61
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30260.Mean reticulocyte volume,50855,0.0083213651882681,0.00180377020505897,0.00478597558635253,0.0118567547901837,3.98151683178879e-06
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30270.Mean sphered cell volume,50855,-0.0014128076656659,0.00182199477635481,-0.00498391742732134,0.00215830209598953,0.438099608095363
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30280.Immature reticulocyte fraction,50855,0.0215398443594046,0.00189580082392236,0.0178240747445168,0.0252556139742924,7.59545629861254e-30
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30290.High light scatter reticulocyte percentage,50855,0.0337913592530526,0.00192266728566844,0.0300229313731424,0.0375597871329627,9.39717321109972e-69
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30300.High light scatter reticulocyte count,50855,0.0349498853169633,0.00197224347455948,0.0310842881068267,0.0388154825270999,7.35086206908102e-70
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30500.Microalbumin in urine,32202,0.0252165844727155,0.00356479261640987,0.0182295909445521,0.0322035780008788,1.63909072869123e-12
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,51398,-0.00215364609808046,0.00188649877909823,-0.00585118370511299,0.00154389150895208,0.253626260269405
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30520.Potassium in urine,51344,-0.00144883235390087,0.00175598687031139,-0.0048905666197112,0.00199290191190946,0.409332617061641
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30530.Sodium in urine,51314,0.00688738273883496,0.00185075871003515,0.00325989566716607,0.0105148698105039,0.000198538204747327
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30600.Albumin,48558,-0.0104293243629838,0.00193507021894574,-0.0142220619921174,-0.00663658673385012,7.12628333905523e-08
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30610.Alkaline phosphatase,50939,0.0310792725728966,0.00183180205604847,0.0274889405430415,0.0346696046027516,3.17650234971593e-64
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30620.Alanine aminotransferase,50948,0.0512975032070495,0.00189528655852379,0.0475827415523428,0.0550122648617561,3.63882955872364e-159
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30630.Apolipoprotein A,48341,-0.022718216729273,0.00211875333612082,-0.0268709732680698,-0.0185654601904761,9.18905353370053e-27
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30640.Apolipoprotein B,50837,0.00536736020057225,0.00183067050051431,0.0017792460195642,0.00895547438158031,0.00337174152371978
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30650.Aspartate aminotransferase,50867,0.0586999311866708,0.0018195916236634,0.0551335316042905,0.062266330769051,5.66682124995159e-224
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30660.Direct bilirubin,45054,0.0101301138683127,0.00211003526634056,0.00599444474628522,0.0142657829903402,1.59045250036656e-06
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30670.Urea,50934,-0.0346613289833208,0.00190408364177481,-0.0383933329211994,-0.0309293250454422,1.3574367027152e-73
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30680.Calcium,48564,-0.001135765337031,0.00185823013878115,-0.00477789640904206,0.00250636573498006,0.541067574798208
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30690.Cholesterol,50947,-0.00786132955929515,0.00188558403239668,-0.0115570742627926,-0.00416558485579766,3.0667534571182e-05
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30700.Creatinine,50940,-0.0156432876397753,0.00209061889664035,-0.0197409006771904,-0.0115456746023603,7.51238601938606e-14
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30710.C-reactive protein,50881,0.0386410296277431,0.00200080356963609,0.0347194546312563,0.0425626046242298,1.55610582225322e-82
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30720.Cystatin C,50942,0.0547346238316055,0.00203013826426909,0.0507555528336381,0.0587136948295729,5.74877726553418e-158
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30730.Gamma glutamyltransferase,50943,0.051297519073133,0.0018556047415502,0.0476605337796946,0.0549345043665714,7.3285093716875e-166
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30740.Glucose,48538,0.0172158546343764,0.00200610857715774,0.0132838818231473,0.0211478274456056,9.90194680961646e-18
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),50786,0.0122223435470302,0.00205118389818598,0.0082020231065857,0.0162426639874748,2.57517471665416e-09
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30760.HDL cholesterol,48551,-0.042172082623183,0.00221561155746651,-0.0465146812758174,-0.0378294839705487,3.45540663831785e-80
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30770.IGF-1,50798,-0.0388295005439159,0.00182889975212756,-0.0424141440580859,-0.0352448570297458,3.34698014442244e-99
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30780.LDL direct,50890,-0.00271025489896651,0.00183812337212971,-0.00631297670834075,0.000892466910407732,0.140367416498407
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30790.Lipoprotein A,45654,-0.00674644609891873,0.00199763450516572,-0.0106618097290435,-0.00283108246879392,0.000733547307485545
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30810.Phosphate,48517,-0.00458085865939302,0.00200337003335839,-0.00850746392477546,-0.000654253394010583,0.0222292040314278
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30830.SHBG,48290,0.0163691646652599,0.00210647372172236,0.0122404761706841,0.0204978531598358,8.1074651919788e-15
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30840.Total bilirubin,50849,-0.0011918833185306,0.00184894526759743,-0.00481581604302157,0.00243204940596037,0.51917338616839
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30850.Testosterone,46426,0.00550345127806095,0.00324642299231587,-0.000859537786878149,0.011866440343,0.0900449358701982
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30860.Total protein,48555,0.0265249199993018,0.00188277402705474,0.0228346829062745,0.0302151570923291,6.76537176746809e-45
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30870.Triglycerides,50937,0.0387699999906739,0.00203109812480275,0.0347890476660605,0.0427509523152873,1.103166905084e-80
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30880.Urate,50910,0.0189945904413542,0.00224296794547103,0.014598373268231,0.0233908076144774,2.61263424763556e-17
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30890.Vitamin D,49413,-0.0193341189248341,0.00200680825846039,-0.0232674631114165,-0.0154007747382518,6.2567764747073e-22
PLA2G15,Phospholipase A2 group XV,Physical measures,X3137.Number of measurements made,49830,0.0859043533448263,0.0484546872713934,-0.00906683370710473,0.180875540396757,0.0762605612149774
PLA2G15,Phospholipase A2 group XV,Physical measures,X3143.Ankle spacing width,40237,0.0160855188337119,0.00312589550095386,0.00995876365184234,0.0222122740155815,2.69445877716225e-07
PLA2G15,Phospholipase A2 group XV,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",40236,-0.00702138400290516,0.0025386503478242,-0.0119971386846406,-0.00204562932116972,0.00568503801620538
PLA2G15,Phospholipase A2 group XV,Physical measures,X3146.Speed of sound through heel,40237,-0.010864107843096,0.0024464020510204,-0.015659055863096,-0.00606915982309604,9.02121450781719e-06
PLA2G15,Phospholipase A2 group XV,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",40237,-0.00997247125910785,0.00247739925756586,-0.0148281738039369,-0.00511676871427877,5.71491779444008e-05
PLA2G15,Phospholipase A2 group XV,Physical measures,X3148.Heel bone mineral density (BMD),40235,-0.00986816367613261,0.00247095651816445,-0.0147112384517349,-0.00502508890053028,6.53555754833684e-05
PLA2G15,Phospholipase A2 group XV,Health and medical history,X3526.Mother's age at death,40964,-0.00465993633469608,0.00238094113409811,-0.00932658095752838,6.7082881362087e-06,0.0503428386404598
PLA2G15,Phospholipase A2 group XV,Health and medical history,X3581.Age at menopause (last menstrual period),40353,-0.0109415118909625,0.00232608601357401,-0.0155006404775676,-0.00638238330435746,2.57473551354315e-06
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",30196,-0.00656106481215385,0.00386947984930109,-0.014145245316784,0.00102311569247628,0.0900170872687211
PLA2G15,Phospholipase A2 group XV,Physical measures,X4100.Ankle spacing width (left),33377,0.0133574887141764,0.00421281950667915,0.00510036248108529,0.0216146149472676,0.00152598705048693
PLA2G15,Phospholipase A2 group XV,Physical measures,X4101.Heel broadband ultrasound attenuation (left),33375,-0.00764007313562192,0.00345213830756176,-0.014406264218443,-0.000873882052800876,0.0269130488606323
PLA2G15,Phospholipase A2 group XV,Physical measures,X4103.Speed of sound through heel (left),33377,-0.0153605199939538,0.00335927351446719,-0.0219446960823095,-0.00877634390559815,4.88261187439869e-06
PLA2G15,Phospholipase A2 group XV,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",33377,-0.0132267259027938,0.00338900507382318,-0.0198691758474872,-0.00658427595810034,9.57717944910356e-05
PLA2G15,Phospholipase A2 group XV,Physical measures,X4105.Heel bone mineral density (BMD) (left),33375,-0.0130404889142606,0.00337873045902644,-0.0196628006139524,-0.0064181772145688,0.00011438177409328
PLA2G15,Phospholipase A2 group XV,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",33377,-0.0132253944356219,0.0033888161299777,-0.0198674740503782,-0.0065833148208656,9.58410873528523e-05
PLA2G15,Phospholipase A2 group XV,Physical measures,X4119.Ankle spacing width (right),33380,0.0147218509865144,0.00415888683170633,0.00657043279636998,0.0228732691766588,0.00040238667080731
PLA2G15,Phospholipase A2 group XV,Physical measures,X4120.Heel broadband ultrasound attenuation (right),33380,-0.00926761935038636,0.0034513782489602,-0.0160323207183483,-0.00250291798242436,0.00726217202434431
PLA2G15,Phospholipase A2 group XV,Physical measures,X4122.Speed of sound through heel (right),33380,-0.0142860858825251,0.00337007477021378,-0.0208914324321441,-0.00768073933290608,2.26676255424664e-05
PLA2G15,Phospholipase A2 group XV,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",33380,-0.0129897550902771,0.00339515867204021,-0.0196442660874759,-0.00633524409307824,0.00013114938868964
PLA2G15,Phospholipase A2 group XV,Physical measures,X4124.Heel bone mineral density (BMD) (right),33377,-0.0127225767309312,0.00338677032545634,-0.0193606465688257,-0.00608450689303681,0.000173367384564588
PLA2G15,Phospholipase A2 group XV,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",33380,-0.0129896283846311,0.00339516730116617,-0.0196441562949168,-0.00633510047434546,0.000131174398574375
PLA2G15,Phospholipase A2 group XV,Physical measures,X4194.Pulse rate,33647,0.0273567645979387,0.00328199000824368,0.0209240641817811,0.0337894650140963,8.83263053259706e-17
PLA2G15,Phospholipase A2 group XV,Physical measures,X4195.Pulse wave reflection index,33647,-0.000220753345406659,0.0033025704431364,-0.006693791413954,0.00625228472314068,0.94670823351211
PLA2G15,Phospholipase A2 group XV,Physical measures,X4196.Pulse wave peak to peak time,33644,-0.0138855876635917,0.00300692103139886,-0.0197791528851335,-0.00799202244204998,3.92952793564539e-06
PLA2G15,Phospholipase A2 group XV,Physical measures,X4198.Position of the pulse wave peak,33647,0.0167215601543657,0.00291114582616455,0.0110157143350831,0.0224274059736482,9.54171527649694e-09
PLA2G15,Phospholipase A2 group XV,Physical measures,X4199.Position of pulse wave notch,33647,0.0151938624813936,0.00324302453208742,0.00883753439850227,0.021550190564285,2.83853216549966e-06
PLA2G15,Phospholipase A2 group XV,Physical measures,X4200.Position of the shoulder on the pulse waveform,33647,0.0179352819807227,0.00290703687185528,0.0122374897118864,0.0236330742495591,7.1347428785845e-10
PLA2G15,Phospholipase A2 group XV,Physical measures,X4269.Number of triplets attempted (left),33545,0.17730215358666,0.210771479833726,-0.235809946887442,0.590414254060763,0.400254906858073
PLA2G15,Phospholipase A2 group XV,Physical measures,X4270.Volume level set by participant (left),33456,-0.00322987218665151,0.0666434353188318,-0.133851005411562,0.127391261038259,0.961346755671415
PLA2G15,Phospholipase A2 group XV,Physical measures,X4276.Number of triplets attempted (right),33545,0.0583817218432299,0.201693304627826,-0.336937155227309,0.453700598913769,0.772237595815429
PLA2G15,Phospholipase A2 group XV,Physical measures,X4277.Volume level set by participant (right),33439,0.00252298033391357,0.0659179005216176,-0.126676104688457,0.131722065356284,0.969469604011042
PLA2G15,Phospholipase A2 group XV,Cognitive function,X4288.Time to answer,33720,-0.00524674227971332,0.00366599298443302,-0.012432088529202,0.0019386039697754,0.152408721871872
PLA2G15,Phospholipase A2 group XV,Cognitive function,X4290.Duration screen displayed,33720,0.0028393736250386,0.0032782531416853,-0.00358600253266459,0.00926474978274179,0.386444602262812
PLA2G15,Phospholipase A2 group XV,Physical measures,X46.Hand grip strength (left),52165,-0.0299643356810114,0.00266092259573529,-0.0351797439686526,-0.0247489273933702,2.37088842918882e-29
PLA2G15,Phospholipase A2 group XV,Physical measures,X47.Hand grip strength (right),52170,-0.0279621040346004,0.0026535867414469,-0.0331631340478363,-0.0227610740213644,6.497262756959e-26
PLA2G15,Phospholipase A2 group XV,Physical measures,X48.Waist circumference,52256,0.0452734163388365,0.00354768691246743,0.0383199499904003,0.0522268826872726,3.42566548144404e-37
PLA2G15,Phospholipase A2 group XV,Health and medical history,X4803.Tinnitus,33553,0.0599354446195088,0.0802157985874794,-0.0972875206119508,0.217158409850968,0.45497569715048
PLA2G15,Phospholipase A2 group XV,Working and living environment,X4825.Noisy workplace,33692,0.227832683515987,0.113861160075464,0.00466480976807671,0.451000557263897,0.0454249044333334
PLA2G15,Phospholipase A2 group XV,Working and living environment,X4836.Loud music exposure frequency,33635,0.125135643647971,0.130645495444585,-0.130929527423416,0.381200814719359,0.338175760995246
PLA2G15,Phospholipase A2 group XV,Physical measures,X49.Hip circumference,52253,-0.0255574972601354,0.00301123790931973,-0.0314595235624021,-0.0196554709578687,2.21725372810876e-17
PLA2G15,Phospholipase A2 group XV,Physical measures,X50.Standing height,52251,0.00406316055327985,0.00246904164335137,-0.000776161067688839,0.00890248217424853,0.0998486312013483
PLA2G15,Phospholipase A2 group XV,Health and medical history,X5057.Number of older siblings,32618,-0.00348055197267959,0.0699917662520496,-0.140664413826697,0.133703309881338,0.960340343447904
PLA2G15,Phospholipase A2 group XV,Physical measures,X51.Seated height,52122,0.00134879651197379,0.00247620465496956,-0.00350456461176654,0.00620215763571412,0.585962077679119
PLA2G15,Phospholipase A2 group XV,Eye measures,X5181.Ever had eye surgery,30703,-0.119015395862801,0.161223570267467,-0.435013593587035,0.196982801861434,0.46042005495447
PLA2G15,Phospholipase A2 group XV,Eye measures,X5186.Duration visual-acuity screen displayed (right),30686,0.00475029308442997,0.00375168788185849,-0.00260301516401266,0.0121036013328726,0.205497777721916
PLA2G15,Phospholipase A2 group XV,Eye measures,X5188.Duration visual-acuity screen displayed (left),30688,-0.000205034200173515,0.00371908637103374,-0.00749444348739964,0.00708437508705261,0.95603645455667
PLA2G15,Phospholipase A2 group XV,Eye measures,X5190.Duration at which refractometer first shown (right),30612,-0.00236971824289515,0.00374919514605712,-0.0097181407291671,0.00497870424337681,0.527370786893504
PLA2G15,Phospholipase A2 group XV,Eye measures,X5193.Duration at which refractometer first shown (left),30613,-0.000342638091600229,0.00377398741092884,-0.00773965341702075,0.00705437723382029,0.927662876054001
PLA2G15,Phospholipase A2 group XV,Eye measures,"X5199.logMAR, initial (right)",30667,0.137138407562171,0.0846171620771491,-0.0287112301090412,0.302988045233383,0.105134322130028
PLA2G15,Phospholipase A2 group XV,Eye measures,X5200.Final number of letters displayed (right),30667,0.206252525508379,0.620808364579768,-1.01053186906797,1.42303692008472,0.73972514279878
PLA2G15,Phospholipase A2 group XV,Eye measures,"X5201.logMAR, final (right)",30616,0.00805268854241191,0.00391058344320026,0.0003879449937394,0.0157174320910844,0.0395166256584017
PLA2G15,Phospholipase A2 group XV,Eye measures,X5202.Number of rounds to result (right),30667,0.00971126748112937,0.0792445032421367,-0.145607958873458,0.165030493835717,0.902468882376058
PLA2G15,Phospholipase A2 group XV,Eye measures,"X5206.logMAR, initial (left)",30665,0.137901137729735,0.0845285595431794,-0.0277748389748964,0.303577114434367,0.102853527814557
PLA2G15,Phospholipase A2 group XV,Eye measures,X5207.Final number of letters displayed (left),30665,-0.557785349500757,0.498951614679405,-1.53573051427239,0.420159815270876,0.263646659776205
PLA2G15,Phospholipase A2 group XV,Eye measures,"X5208.logMAR, final (left)",30601,0.00666481065560429,0.00387599421317954,-0.000932138002227606,0.0142617593134362,0.0855718791650955
PLA2G15,Phospholipase A2 group XV,Eye measures,X5209.Number of rounds to result (left),30663,0.0532997817848015,0.078872237364,-0.101289803448639,0.207889367018241,0.499209554529934
PLA2G15,Phospholipase A2 group XV,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",30366,0.00615137005975926,0.00385158024268803,-0.00139772721590928,0.0137004673354278,0.110296193221052
PLA2G15,Phospholipase A2 group XV,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",30366,0.0104891401827913,0.00388019934946121,0.00288394945784735,0.0180943309077353,0.00688617991109465
PLA2G15,Phospholipase A2 group XV,Eye measures,X5256.Corneal hysteresis (right),30366,0.00386028829330559,0.00385678569944706,-0.00369901167761065,0.0114195882642218,0.316912159546992
PLA2G15,Phospholipase A2 group XV,Eye measures,X5257.Corneal resistance factor (right),30366,0.00900448530379594,0.00385995241271622,0.00143897857487216,0.0165699920327197,0.0196921698245147
PLA2G15,Phospholipase A2 group XV,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",30364,0.00544161416434558,0.0038441692164728,-0.0020929574999411,0.0129761858286323,0.156959941785731
PLA2G15,Phospholipase A2 group XV,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",30364,0.00627203985720898,0.003824475225073,-0.0012239315839341,0.0137680112983521,0.101063778653151
PLA2G15,Phospholipase A2 group XV,Eye measures,X5264.Corneal hysteresis (left),30364,0.00213498229869246,0.00392004517967243,-0.00554830625346551,0.00981827085085043,0.586027139153997
PLA2G15,Phospholipase A2 group XV,Eye measures,X5265.Corneal resistance factor (left),30364,0.00505703596313363,0.00387608304837567,-0.00254008681168268,0.0126541587379499,0.192053678321594
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,29928,0.549222262696605,0.367799117341078,-0.171664007291908,1.27010853268512,0.135424948449009
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",52162,0.0361428079167369,0.0103927065492969,0.015773103080115,0.0565125127533588,0.000506494294057877
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",52162,0.020775181162552,0.0106827899750741,-0.000163087188593172,0.0417134495136971,0.0518171465421979
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",52162,-0.00312078743324742,0.0273613808130197,-0.056749093826766,0.0505075189602712,0.909192553694436
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",52162,-0.0105925679969951,0.00452303674526285,-0.0194577200177103,-0.00172741597627997,0.0191921222386941
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",52162,-0.000266291911646907,0.00413516121666683,-0.00837120789631389,0.00783862407302008,0.948654595802083
PLA2G15,Phospholipase A2 group XV,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",37287,-0.0132212261054355,0.00516305195416829,-0.0233408079356054,-0.00310164427526564,0.0104563275844258
PLA2G15,Phospholipase A2 group XV,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",37287,0.00972831331589296,0.0129328647134043,-0.0156201015223794,0.0350767281541653,0.451934709261602
PLA2G15,Phospholipase A2 group XV,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",37287,-0.0152272669855258,0.0100823787696296,-0.0349887293739998,0.0045341954029483,0.130995294836314
PLA2G15,Phospholipase A2 group XV,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",37287,0.013657052962259,0.00620356460436775,0.00149806633769822,0.0258160395868198,0.0277194546704182
PLA2G15,Phospholipase A2 group XV,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,52248,0.00501286350091175,0.00850265205688862,-0.0116523345305899,0.0216780615324135,0.555487316114454
PLA2G15,Phospholipase A2 group XV,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,52248,0.00501286350091175,0.00850265205688862,-0.0116523345305899,0.0216780615324135,0.555487316114454
PLA2G15,Phospholipase A2 group XV,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),52248,-0.00604384987208657,0.00679891573430058,-0.0193697247113157,0.00728202496714256,0.374041302427076
PLA2G15,Phospholipase A2 group XV,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',52248,-0.00907778332707872,0.0106250094379887,-0.0299028018255365,0.0117472351713791,0.392902475019481
PLA2G15,Phospholipase A2 group XV,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),52248,0.0147777975228401,0.0261688827518712,-0.0365132126708275,0.0660688077165076,0.5722764269142
PLA2G15,Phospholipase A2 group XV,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),52248,-0.00525218218478742,0.0180185894677901,-0.040568617541656,0.0300642531720812,0.770681162041478
PLA2G15,Phospholipase A2 group XV,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,52248,0.0805809233794133,0.0294396752470653,0.0228791598951654,0.138282686863661,0.00620126749086189
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,52162,0.0208174535544761,0.00547324045147857,0.0100899022695781,0.031545004839374,0.000142973757780553
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,52162,0.0281510944145453,0.0091403878528688,0.0102359342229225,0.0460662546061682,0.00207302119357046
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,52162,0.00510831471275993,0.00484899985784242,-0.0043957250086112,0.0146123544341311,0.292131154001878
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,52162,0.035487678087204,0.00899341605616844,0.0178605826171139,0.0531147735572942,7.96760984916939e-05
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,52162,0.0210825269994451,0.00876355557728398,0.00390595806796851,0.0382590959309217,0.0161478142060959
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,52162,0.0482332039090465,0.00490316624282701,0.0386229980731056,0.0578434097449875,8.48787997043184e-23
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,31885,0.0364482108714982,0.0190322967941493,-0.000855090845034316,0.0737515125880308,0.0555217111496582
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,31885,0.0122660257765214,0.0125003646230682,-0.0122346888846923,0.0367667404377351,0.326499714004794
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,31885,0.0387818065133478,0.0160346496609732,0.0073538931778403,0.0702097198488552,0.0156031546980007
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,31885,-0.00147037270187554,0.0142176162142676,-0.0293369004818401,0.026396155078089,0.917633164553476
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,52157,0.00329220267847306,0.0132905406208553,-0.0227572569384033,0.0293416622953494,0.804360463207744
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6151#2.Fractured bone site(s)_Leg,52157,-0.0268752057583622,0.0228736804501385,-0.0717076194406337,0.0179572079239093,0.240028755164483
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6151#3.Fractured bone site(s)_Hip,52157,0.115458034432679,0.0360927498646771,0.0447162446979118,0.186199824167446,0.00138095783951572
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6151#4.Fractured bone site(s)_Spine,52157,0.0698854786716636,0.0358007566420353,-0.000284004346725625,0.140054961690053,0.0509402996381142
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,52157,0.00454934627651718,0.0111345576087459,-0.0172743866366249,0.0263730791896592,0.682851811265573
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6151#6.Fractured bone site(s)_Arm,52157,0.0385915585365217,0.0158412664946908,0.0075426762069278,0.0696404408661156,0.0148511544585759
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,52157,0.0122671621413394,0.0078740230802065,-0.00316592309586538,0.0277002473785441,0.119261705637791
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",33983,0.0451956912832985,0.0118773837368796,0.0219160191590145,0.0684753634075825,0.000142582278767465
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",33983,0.0514918423365538,0.0137881200261366,0.0244671270853261,0.0785165575877814,0.000189178889907616
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",33983,-0.00598838836330382,0.0180139155532371,-0.0412956628476485,0.0293188861210409,0.739570959904593
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",33983,0.00801683276587008,0.00621438188136915,-0.00416335572161346,0.0201970212533536,0.197066305410839
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",37553,0.00156492126282925,0.0064532827132536,-0.0110835128551478,0.0142133553808063,0.808396528292729
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",37553,-0.0130348556024774,0.00563341220652833,-0.024076343527273,-0.0019933676776819,0.0206914963027369
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",37553,-0.0022487413019741,0.00528470061553772,-0.012606754508428,0.00810927190447983,0.670465255746346
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",37553,0.0195016110678968,0.012709832136339,-0.00540965991932764,0.0444128820551212,0.124962299516331
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",37553,0.0604456580750108,0.00759248249062367,0.0455643923933884,0.0753269237566332,1.84273442301449e-15
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",37553,-0.0125079316950801,0.00879506234277616,-0.0297462538869214,0.00473039049676115,0.155005402071926
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,52162,-0.0186085941160455,0.0120057145977356,-0.0421397947276072,0.00492260649551621,0.121158204407801
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,52162,0.00900879473425708,0.00767696472191013,-0.00603805612068678,0.0240556455892009,0.24061188366204
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,52162,-0.0176286994480838,0.0300239165553522,-0.0764755758965742,0.0412181770004065,0.557104245169879
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,52162,0.00132368084923561,0.0075748199734213,-0.0135229662986701,0.0161703279971414,0.861279319481766
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,52162,-0.00864214957215507,0.00911184632562257,-0.0265013683703753,0.00921706922606516,0.342907629894629
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),52162,0.0528876573706979,0.010198336944383,0.0328989169597072,0.0728763977816886,2.16472477975121e-07
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,52162,0.0022113933475677,0.00361507889952478,-0.00487416129550088,0.00929694799063627,0.540732204015006
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,28840,0.0112485947349371,0.012198366314709,-0.0126602032418925,0.0351573927117668,0.35650653093601
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,28840,0.0380474453422898,0.0160434190031956,0.00660234409602634,0.0694925465885533,0.0177575328760346
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,28840,-0.0237376457435127,0.01068774218383,-0.0446856204238196,-0.0027896710632059,0.0264007303732044
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,28840,-0.000111942283416697,0.00968306458283874,-0.0190907488657806,0.0188668642989472,0.990776686279147
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,52290,0.0100388861900485,0.00412121212242321,0.00196131043009904,0.018116461949998,0.0148607647124255
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,52290,0.0200379282280107,0.0110490143019424,-0.00161813980379629,0.0416939962598178,0.0697579598540396
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,52290,0.0165405413565985,0.00402547967802441,0.00865060118767065,0.0244304815255263,3.98578905440571e-05
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,52290,0.00778843880510054,0.00401460096379415,-8.0179083935982e-05,0.0156570566941371,0.0523863572464643
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,52290,0.0452683407933534,0.00577646902395926,0.0339464615063933,0.0565902200803136,4.79051667422721e-15
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,52290,0.00921734494487417,0.00512679935089117,-0.000831181782872522,0.0192658716726209,0.0722076327958947
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,52290,0.00764367282462443,0.00430268094698425,-0.000789581831464705,0.0160769274807136,0.0756629869513856
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,52290,0.0803410845177709,0.0117135845277327,0.0573824588434148,0.103299710192127,7.08950606566991e-12
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,43614,-0.0224408047105879,0.00421080550350411,-0.0306939834974559,-0.0141876259237198,9.96861588889085e-08
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,43614,0.00430318332701664,0.00467230653102758,-0.00485453747379741,0.0134609041278307,0.357063249502324
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,43614,0.00906749480284419,0.00468746122326209,-0.000119929194749494,0.0182549188004379,0.053076839465659
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,43614,-0.0161132139118422,0.00597621810677436,-0.02782660140112,-0.00439982642256449,0.00701920593931824
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,43614,-0.00570115500387818,0.00424558702778694,-0.0140225055783406,0.00262019557058422,0.179338860754161
PLA2G15,Phospholipase A2 group XV,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,52040,-0.00251781885213295,0.00434854078115022,-0.0110409587831874,0.00600532107892147,0.562591768376849
PLA2G15,Phospholipase A2 group XV,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,52040,-0.0126006849995472,0.00349680932019503,-0.0194544312671294,-0.00574693873196492,0.00031453627060854
PLA2G15,Phospholipase A2 group XV,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,52040,0.00230968518183905,0.00382553344145079,-0.0051883603634045,0.0098077307270826,0.546011464180689
PLA2G15,Phospholipase A2 group XV,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,52040,-0.0267814548093991,0.00837507453564207,-0.0431966008992575,-0.0103663087195406,0.00138657118940355
PLA2G15,Phospholipase A2 group XV,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),52052,-0.0282728075147932,0.00394767175817252,-0.0360102441608113,-0.020535370868775,8.15614644630994e-13
PLA2G15,Phospholipase A2 group XV,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,52052,-0.0337842708848145,0.00708454116580493,-0.0476699715697922,-0.0198985701998369,1.86335487528514e-06
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),52162,-0.0169895243777027,0.00377752164809633,-0.0243934668079715,-0.00958558194743395,6.90256858990558e-06
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,52162,-0.0276290916815083,0.00428420738769108,-0.0360261381613829,-0.0192320452016338,1.14402581018748e-10
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,52162,-0.0024994070438647,0.00560219084504686,-0.0134797011001565,0.00848088701242714,0.655493724625059
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,52162,-0.0127622179809849,0.00811010559470145,-0.0286580249465997,0.00313358898462997,0.115586925449566
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,52162,0.0233538357299892,0.00833876937403868,0.00700984775687342,0.039697823703105,0.0051037745907668
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,52162,-0.0294424727595258,0.0108477544221817,-0.050704071427002,-0.00818087409204954,0.00664864311648434
PLA2G15,Phospholipase A2 group XV,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",40237,-0.00997179608357761,0.00247739488206354,-0.0148274900524221,-0.00511610211473308,5.72136104348468e-05
PLA2G15,Phospholipase A2 group XV,Physical activities,X864.Number of days or week walked 10+ minutes,51648,-0.177839930519742,0.0389307625152145,-0.254144225049562,-0.101535635989921,4.9430599754702e-06
PLA2G15,Phospholipase A2 group XV,Physical activities,X874.Duration of walks,47545,-0.00568603448732595,0.00193443698024061,-0.00947753096859755,-0.00189453800605436,0.00329201177692296
PLA2G15,Phospholipase A2 group XV,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,50568,-0.146450172659929,0.0379486053330342,-0.220829439112677,-0.0720709062071823,0.000114045724194422
PLA2G15,Phospholipase A2 group XV,Physical activities,X894.Duration of moderate activity,44371,-0.148729414108844,0.04667759961925,-0.240217509362574,-0.0572413188551142,0.00144321182936891
PLA2G15,Phospholipase A2 group XV,Physical activities,X90087.No-wear time bias adjusted average acceleration,30486,-0.00539721256276688,0.00395858374012051,-0.0131560366934031,0.00236161156786931,0.17280102219842
PLA2G15,Phospholipase A2 group XV,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,50563,-0.267852765964095,0.0394803409770423,-0.345234234279098,-0.190471297649092,1.19011425039705e-11
PLA2G15,Phospholipase A2 group XV,Physical activities,X914.Duration of vigorous activity,38210,-0.00109301481961052,0.00254130326963191,-0.00607396922808907,0.00388793958886802,0.667129555425438
